<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">06074</article-id><article-id pub-id-type="doi">10.7554/eLife.06074</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry</subject></subj-group><subj-group subj-group-type="heading"><subject>Biophysics and Structural Biology</subject></subj-group></article-categories><title-group><article-title>Autoinhibition of Bruton's tyrosine kinase (Btk) and activation by soluble inositol hexakisphosphate</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-22979"><name><surname>Wang</surname><given-names>Qi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-23431"><name><surname>Vogan</surname><given-names>Erik M</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-23432"><name><surname>Nocka</surname><given-names>Laura M</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-23433"><name><surname>Rosen</surname><given-names>Connor E</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-29287"><name><surname>Zorn</surname><given-names>Julie A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" corresp="yes" id="author-2915"><name><surname>Harrison</surname><given-names>Stephen C</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-1018"><name><surname>Kuriyan</surname><given-names>John</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Department of Molecular and Cell Biology</institution>, <institution>Howard Hughes Medical Institute, University of California, Berkeley</institution>, <addr-line><named-content content-type="city">Berkeley</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">California Institute for Quantitative Biosciences</institution>, <institution>University of California, Berkeley</institution>, <addr-line><named-content content-type="city">Berkeley</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><label>3</label><institution>Beryllium Inc</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><label>4</label><institution content-type="dept">Laboratory of Molecular Medicine</institution>, <institution>Harvard Medical School, Howard Hughes Medical Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><label>5</label><institution content-type="dept">Department of Chemistry</institution>, <institution>University of California, Berkeley</institution>, <addr-line><named-content content-type="city">Berkeley</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><label>6</label><institution content-type="dept">Physical Biosciences Division</institution>, <institution>Lawrence Berkeley National Laboratory</institution>, <addr-line><named-content content-type="city">Berkeley</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-21020"><name><surname>Cole</surname><given-names>Philip A</given-names></name><role>Reviewing editor</role><aff><institution>Johns Hopkins University School of Medicine</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>harrison@crystal.harvard.edu</email> (SCH);</corresp><corresp id="cor2"><email>jkuriyan@mac.com</email> (JK)</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>20</day><month>02</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>4</volume><elocation-id>e06074</elocation-id><history><date date-type="received"><day>13</day><month>12</month><year>2014</year></date><date date-type="accepted"><day>19</day><month>02</month><year>2015</year></date></history><permissions><copyright-statement>© 2015, Wang et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Wang et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-06074-v2.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.06074.001</object-id><p>Bruton's tyrosine kinase (Btk), a Tec-family tyrosine kinase, is essential for B-cell function. We present crystallographic and biochemical analyses of Btk, which together reveal molecular details of its autoinhibition and activation. Autoinhibited Btk adopts a compact conformation like that of inactive c-Src and c-Abl. A lipid-binding PH-TH module, unique to Tec kinases, acts in conjunction with the SH2 and SH3 domains to stabilize the inactive conformation. In addition to the expected activation of Btk by membranes containing phosphatidylinositol triphosphate (PIP<sub>3</sub>), we found that inositol hexakisphosphate (IP<sub>6</sub>), a soluble signaling molecule found in both animal and plant cells, also activates Btk. This activation is a consequence of a transient PH-TH dimerization induced by IP<sub>6</sub>, which promotes transphosphorylation of the kinase domains. Sequence comparisons with other Tec-family kinases suggest that activation by IP<sub>6</sub> is unique to Btk.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.06074.001">http://dx.doi.org/10.7554/eLife.06074.001</ext-link></p></abstract><abstract abstract-type="executive-summary"><object-id pub-id-type="doi">10.7554/eLife.06074.002</object-id><title>eLife digest</title><p>The human immune system is our defense against a variety of intruders, including bacteria, viruses, and other microbes, and provides our body with long-lasting protection against these invaders. B-cells—one type of immune cell—produce proteins called antibodies that can recognize microbes from previous invasions. This allows other immune cells to find the intruders and destroy them more efficiently.</p><p>People suffering from a genetic disease called X-linked agammaglobulinemia have fewer fully mature B-cells than most people and are extremely susceptible to bacterial infections. The disease is caused by mutations in the gene encoding an enzyme called Bruton's tyrosine kinase (Btk), which is involved in B-cell development. This enzyme is usually kept inactive until the B-cells are needed, but the molecular mechanism of this restraint remains to be discovered.</p><p>Wang et al. have used X-ray crystallography and biochemistry to produce a three-dimensional atomic model of the Btk enzyme in its inactive form. The model and functional studies reveal that when the Btk enzyme is inactive, it folds up into a compact shape. Within the enzyme, a ‘PH-TH module’ and two other domains work together to stabilize this folded-up form.</p><p>Although earlier studies indicated that the Btk enzyme becomes activated only when it is recruited to cell membranes, Wang et al. found that a small molecule called IP<sub>6</sub> (short for inositol hexakisphosphate) can activate the Btk enzyme even in the absence of a membrane. This molecule recognizes a previously unnoticed binding site on the PH-TH module, and causes the PH-TH module in the inactive Btk enzyme to bind briefly to the PH-TH modules in other Btk enzymes. This brief binding event is an important step in the process that activates the enzyme. IP<sub>6</sub> might also be involved in recruiting the Btk enzyme to the cell membrane in B cells, but this proposal needs to be tested experimentally. The details of the BTK activation mechanism reported by Wang et al. could prove useful to researchers developing new treatments for immunodeficiency diseases.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.06074.002">http://dx.doi.org/10.7554/eLife.06074.002</ext-link></p></abstract><kwd-group kwd-group-type="author-keywords"><title>Author keywords</title><kwd>B-cell signalling</kwd><kwd>tyrosine kinase</kwd><kwd>protein structure</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>E. coli</italic></kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000884</institution-id><institution>Cancer Research Institute (CRI)</institution></institution-wrap></funding-source><award-id>postdoctoral fellowship</award-id><principal-award-recipient><name><surname>Wang</surname><given-names>Qi</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health (NIH)</institution></institution-wrap></funding-source><award-id>PO1 AI091580</award-id><principal-award-recipient><name><surname>Kuriyan</surname><given-names>John</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>elife-xml-version</meta-name><meta-value>2.3</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A key B-cell tyrosine kinase that adopts an autoinhibited conformation, and can be activated by either membrane recruitment or soluble inositol hexakisphosphates in solution.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Activation of B- and T-lymphocytes relies on a chain of tyrosine phosphorylation events initiated by B-cell and T-cell receptors, respectively (<xref ref-type="bibr" rid="bib12">Cambier et al., 1993</xref>; <xref ref-type="bibr" rid="bib73">Weiss and Littman, 1994</xref>; <xref ref-type="bibr" rid="bib36">Kurosaki, 2011</xref>). These phosphorylation-dependent signals are generated by three kinds of non-receptor tyrosine kinases, linked to the receptor by membrane co-localization (<xref ref-type="bibr" rid="bib16">Dal Porto et al., 2004</xref>; <xref ref-type="bibr" rid="bib36">Kurosaki, 2011</xref>). Src-family kinases (principally Lyn and Fyn in B-cells, Lck and Fyn in T-cells), resident at the plasma membrane, respond first to receptor activation. They phosphorylate pairs of tyrosine residues in ITAM motifs in the cytoplasmic tails of activated receptors (<xref ref-type="bibr" rid="bib14">Chu et al., 1998</xref>; <xref ref-type="bibr" rid="bib49">Mócsai et al., 2010</xref>; <xref ref-type="bibr" rid="bib71">Wang et al., 2010</xref>), which in turn recruit the tandem-SH2 domain tyrosine kinases Syk (in B-cells) and ZAP-70 (in T-cells). Membrane localization of Syk or ZAP-70 leads to the recruitment and activation of Tec-family tyrosine kinases, Btk (in B-cells) and Itk (in T-cells) (<xref ref-type="bibr" rid="bib2">Andreotti et al., 2010</xref>).</p><p>Btk is present in all hematopoietic cells, except for T-cells and natural killer cells (<xref ref-type="bibr" rid="bib67">Tsukada et al., 1993</xref>; <xref ref-type="bibr" rid="bib42">Lindvall et al., 2005</xref>). It is also part of several other receptor-mediated signaling networks, including those initiated by Toll-like receptors (<xref ref-type="bibr" rid="bib32">Jefferies et al., 2003</xref>), Fc receptors (<xref ref-type="bibr" rid="bib35">Kawakami et al., 1994</xref>), and G-protein coupled receptors (<xref ref-type="bibr" rid="bib68">Tsukada et al., 1994</xref>; <xref ref-type="bibr" rid="bib6">Bence et al., 1997</xref>). Btk is critical for the generation of calcium flux in response to receptor activation, because it activates phospholipase C-γ2 (PLC-γ2), which produces the second messengers diaceylglycerol (DAG) and inositol (1,4,5)-trisphosphate (IP<sub>3</sub>). Btk dysfunction is the cause of X-linked agammaglobulinemia, a severe disease of primary immunodeficiency (<xref ref-type="bibr" rid="bib67">Tsukada et al., 1993</xref>).</p><p>The Tec family kinases have a lipid-interaction module attached to the N terminus of a Src-like module (i.e., concatenation of an SH3 domain, an SH2 domain and a tyrosine kinase domain) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Like the non-receptor tyrosine kinase c-Abl, the Tec kinases lack a C-terminal tyrosine phosphorylation site that in Src kinases engages the SH2 domain in an autoinhibitory interaction (<xref ref-type="bibr" rid="bib62">Sicheri et al., 1997</xref>; <xref ref-type="bibr" rid="bib76">Xu et al., 1997</xref>; <xref ref-type="bibr" rid="bib52">Nagar et al., 2003</xref>). The lipid-interaction module of the Tec kinases is an extended plekstrin homology (PH) domain fused to a Tec homology (TH) domain (<xref ref-type="bibr" rid="bib30">Hyvönen and Saraste, 1997</xref>). The PH-TH binds PIP<sub>3</sub> in membranes, or the soluble head group of PIP<sub>3</sub>, inositol tetrakisphosphate (IP<sub>4</sub>), in solution. A flexible linker connects the PH-TH module to the Src-like module; its length varies from 26 residues in Itk, the Tec family kinase in T-cells, to 45 residues in Btk.<fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.06074.003</object-id><label>Figure 1.</label><caption><title>Crystal structure of the Src-like module of Btk.</title><p>(<bold>A</bold>) Domain architectures of Btk, c-Abl, and c-Src. (<bold>B</bold>) Model for the Src-like module of Btk, based on the crystal structure of the domain-swapped dimer. (<bold>C</bold>) Comparison of the Src-like modules of Btk and c-Abl (PDB: 1OPK) (<xref ref-type="bibr" rid="bib52">Nagar et al., 2003</xref>), superimposed on the C lobes of the kinase domains. There is a relative rotation of about 15° for the SH2 domains and 20° for the SH3 domains for the two structures. (<bold>D</bold>) Details of the SH3/SH2-kinase linker interface and the kinase catalytic cleft in Btk. Left panel: a cluster of hydrophobic residues on the SH3 domain packs against the polyproline type-II helix formed by the SH2-kinase linker. This type of interaction is seen in most SH3-peptide ligand complexes. Right panel: the activation loop of Btk folds into the mouth of the catalytic cleft, blocking part of the ATP-binding cleft. Glu 445, in helix αC, forms an ion pair with Lys 430 in the active conformation but is prevented from doing so in this inactive conformation by the activation loop and helix αC.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.06074.003">http://dx.doi.org/10.7554/eLife.06074.003</ext-link></p><p><supplementary-material id="SD1-data"><object-id pub-id-type="doi">10.7554/eLife.06074.017</object-id><label>Figure 1—source data 1.</label><caption><title>Structures of fragments of Tec family kinases in the Protein Data Bank.</title><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.06074.017">http://dx.doi.org/10.7554/eLife.06074.017</ext-link></p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-06074-fig1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic xlink:href="elife-06074-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.06074.004</object-id><label>Figure 1—figure supplement 1.</label><caption><title>Structural details of the Src-like module of Btk.</title><p>(<bold>A</bold>) The Src-like module of Btk forms a domain-swapped dimer in the crystal lattice, with one molecule per asymmetric unit. The SH3 domain and the kinase domain are intact, but the SH2 domain forms a domain-swapped dimer with another molecule. (<bold>B</bold>) Molecular details of the domain-swapped SH2 dimer in Btk and Grb2 (<xref ref-type="bibr" rid="bib59">Schiering et al., 2000</xref>). The SH2 domain opens up at a position within the β-sheet, so that helix αB of one polypeptide chain packs against the β-sheet of the other. (<bold>C</bold>) Interactions between the SH2-kinase linker and the kinase domain. Leu 390 of the linker stabilizes the inactive conformation of the kinase domain by being sandwiched between residues Trp 421 and Tyr 461 in the kinase domain. (<bold>D</bold>) The ‘electrostatic switch’ in the Btk kinase domain. The active conformation of the Btk kinase domain is modeled from the crystal structure of Lck (PDB: 3LCK) (<xref ref-type="bibr" rid="bib77">Yamaguchi and Hendrickson, 1996</xref>) using Modeller (<xref ref-type="bibr" rid="bib22">Eswar et al., 2006</xref>). Activation entails a shuffling of salt-bridge and polar hydrogen-bond partners.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.06074.004">http://dx.doi.org/10.7554/eLife.06074.004</ext-link></p></caption><graphic xlink:href="elife-06074-fig1-figsupp1-v2.tif"/></fig></fig-group></p><p>Tyrosine phosphorylation controls Btk activity. B-cell activation leads to rapid phosphorylation of Tyr 551 in the kinase domain and Tyr 223 in the SH3 domain of Btk (<xref ref-type="bibr" rid="bib54">Park et al., 1996</xref>; <xref ref-type="bibr" rid="bib56">Rawlings et al., 1996</xref>). Tyr 551 corresponds to the canonical phosphorylation site in the activation loop of tyrosine kinases; as expected, its phosphorylation increases Btk catalytic activity (<xref ref-type="bibr" rid="bib56">Rawlings et al., 1996</xref>). Phosphorylation of Tyr 223 has been reported to have no apparent influence on Btk catalytic activity (<xref ref-type="bibr" rid="bib54">Park et al., 1996</xref>; <xref ref-type="bibr" rid="bib45">Middendorp et al., 2003</xref>). It lies within the peptide-binding groove of the SH3 domain, and its phosphorylation alters SH3 domain selectivity among binding partners (<xref ref-type="bibr" rid="bib48">Morrogh et al., 1999</xref>; <xref ref-type="bibr" rid="bib45">Middendorp et al., 2003</xref>).</p><p>Binding of a Tec-kinase PH domain to the membrane lipid PIP<sub>3</sub>, produced as a consequence of receptor activation, provides a simple control mechanism for switching on the kinase. Membrane recruitment triggers trans-autophosphorylation, through increased local concentration, or trans-phosphorylation by membrane-bound Src-family kinases, thereby activating the Tec kinase (<xref ref-type="bibr" rid="bib56">Rawlings et al., 1996</xref>).</p><p>We present here an analysis of two crystal structures of Btk, which jointly provide molecular details of its autoinhibition. One structure is of the Src-like module, in an assembled and inactive conformation, resembling those of inactive c-Abl and of the Src kinases c-Src and Hck (<xref ref-type="bibr" rid="bib62">Sicheri et al., 1997</xref>; <xref ref-type="bibr" rid="bib76">Xu et al., 1997</xref>; <xref ref-type="bibr" rid="bib52">Nagar et al., 2003</xref>). The other is of a Btk construct that lacks the SH3 and SH2 modules and that links the PH-TH module directly to the kinase domain. We find that the PH-TH module stabilizes the inactive conformation of the kinase by interacting with the N lobe. The inactive conformation of Btk is thus a compact one, in which the PH-TH module cooperates with the SH2 and SH3 domains to maintain an inactive structure. Several structures of isolated domains of Btk have been determined previously, as summarized in <xref ref-type="supplementary-material" rid="SD1-data">Figure 1—source data 1</xref>, which also lists structures of fragments of other Tec family kinases.</p><p>We also report a set of findings that reveal an unanticipated role for the PH-TH module in activating the kinase domain. We find that inositol hexakisphosphate (IP<sub>6</sub>), a soluble signaling molecule ubiquitous in animal and plant cells (<xref ref-type="bibr" rid="bib64">Szwergold et al., 1987</xref>; <xref ref-type="bibr" rid="bib70">Vallejo et al., 1987</xref>), can activate Btk strongly. We have determined a crystal structure of the PH-TH module of Btk bound to IP<sub>6</sub> and identified a previously undetected binding site on the PH-TH module, distinct from the canonical PIP<sub>3</sub>/IP<sub>4</sub> site. The new site is critical for activation by IP<sub>6</sub>.</p><p>We show that Btk activation by IP<sub>6</sub> is a consequence of a transient, IP<sub>6</sub>-induced PH-TH dimerization, which promotes transphosphorylation of the kinase domains. The possibility that PH dimerization might be important for Btk activation was first proposed by Saraste and colleagues (<xref ref-type="bibr" rid="bib30">Hyvönen and Saraste, 1997</xref>), and we now show that the dimer interface identified previously is essential for IP<sub>6</sub>-dependent Btk activation. IP<sub>6</sub>-triggered transient dimerization of the PH domain may provide a membrane-independent mechanism for activating Btk in the nucleus or cytoplasm or may have a role in feedback stimulation of Btk that has been activated by PIP<sub>3</sub> at the membrane. The prior model for Btk activation involved only a PIP<sub>3</sub>-dependent membrane recruitment as the key step in switching on the kinase. The ability of IP<sub>6</sub> to activate Btk points to an as yet unappreciated complexity to the activation mechanism.</p></sec><sec id="s2" sec-type="results|discussion"><title>Results and Discussion</title><sec id="s2-1"><title>Structural analysis of Btk</title><p>We have determined four crystal structures as part of this work. Two of these structures help explain how Btk is autoinhibited. These are the structures of the Btk SH3-SH2-kinase module (determined at 2.6 Å resolution) and of the PH-TH-kinase unit (determined at 1.7 Å resolution). The other two structures are of the isolated PH-TH module bound to IP<sub>6</sub> (determined at 2.3 Å resolution) and the isolated kinase domain with mutations in the activation loop (determined at 1.6 Å). The details of the crystallographic experiments are given in <xref ref-type="table" rid="tbl1 tbl2">Tables 1, 2</xref>.<table-wrap id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.06074.005</object-id><label>Table 1.</label><caption><p>Data collection and refinement statistics</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.06074.005">http://dx.doi.org/10.7554/eLife.06074.005</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Src-like module of mouse Btk (217-659)</th><th>PH-TH-kinase unit of bovine Btk</th><th>Btk PH-TH module bound to IP<sub>6</sub></th><th>Btk kinase domain with mutations in the activation loop</th></tr><tr><th>PDB ID</th><th>4XI2</th><th>4Y93</th><th>4Y94</th><th>4Y95</th></tr></thead><tbody><tr><td colspan="5">Data collection</td></tr><tr><td/><td>KAu(CN)<sub>2</sub></td><td>Native</td><td>Native</td><td>Native</td></tr><tr><td> Wavelength (Å)</td><td>0.9474</td><td>1.000</td><td>1.000</td><td>1.000</td></tr><tr><td> Space group</td><td>P 3<sub>1</sub> 2 1</td><td>P 2 2<sub>1</sub> 2<sub>1</sub></td><td>P 1</td><td>P 1</td></tr><tr><td> <italic>a</italic>,<italic>b</italic>,<italic>c</italic> (Å)</td><td>132.2, 132.2, 107.6</td><td>78.6, 38.3, 157.6</td><td>37.2, 64.0, 80.0</td><td>50.9, 79.0, 79.2</td></tr><tr><td> α,β,γ (°)</td><td>90.0, 90.0, 120.0</td><td>90.0, 90.0, 90.0</td><td>82.0, 88.8, 89.8</td><td>90.7, 89.9, 90.0</td></tr><tr><td> Resolution (Å)</td><td>43.2–2.6</td><td>50–1.7</td><td>43.9–2.3</td><td>47.9–1.6</td></tr><tr><td> <italic>R</italic><sub>sym</sub> (%)</td><td>8.7 (&gt;100)</td><td>12.2 (79.7)</td><td>6.0 (53.8)</td><td>5.1 (71.7)</td></tr><tr><td> <italic>I</italic>/σ(<italic>I</italic>)</td><td>10.6 (1.1)</td><td>17.0 (3.5)</td><td>10.8 (1.2)</td><td>13.2 (3.2)</td></tr><tr><td> Completeness (%)</td><td>91.9 (69.6)</td><td>99.2 (98.5)</td><td>94.9 (71.8)</td><td>96.9 (94.7)</td></tr><tr><td> Redundancy</td><td>4.8 (3.5)</td><td>7.8 (7.4)</td><td>2.0 (1.7)</td><td>24.4 (3.1)</td></tr><tr><td> Wilson B factor</td><td>72.8</td><td>15.7</td><td>52.3</td><td>18.1</td></tr><tr><td colspan="5">Refinement</td></tr><tr><td> Resolution</td><td>43.2–2.6</td><td>50–1.7</td><td>46.5–2.3</td><td>47.9–1.6</td></tr><tr><td> Reflections</td><td>57,643(30,933)</td><td>53,357</td><td>30,516</td><td>157,562</td></tr><tr><td> <italic>R</italic><sub>free</sub> reflections</td><td>1525</td><td>2000</td><td>2025</td><td>2009</td></tr><tr><td> <italic>R</italic><sub>work</sub>/<italic>R</italic><sub>free</sub></td><td>0.237/0.252</td><td>0.167/0.195</td><td>0.236/0.254</td><td>0.155/0.187</td></tr><tr><td colspan="5"> No. atoms</td></tr><tr><td>  Protein</td><td>3459</td><td>6970</td><td>5053</td><td>8911</td></tr><tr><td>  Ligands</td><td>2</td><td>80</td><td>216</td><td>961</td></tr><tr><td>  Water</td><td>0</td><td>525</td><td>39</td><td>737</td></tr><tr><td colspan="5"> Average <italic>B</italic> factors</td></tr><tr><td>  Protein</td><td>114.4</td><td>27.7</td><td>62.1</td><td>22.5</td></tr><tr><td>  Solvent</td><td>N/A</td><td>33.0</td><td>66.2</td><td>30.1</td></tr><tr><td colspan="5"> Root mean square deviation from ideality</td></tr><tr><td>  Bonds (Å)</td><td>0.006</td><td>0.005</td><td>0.003</td><td>0.014</td></tr><tr><td>  Angles (°)</td><td>1.11</td><td>0.977</td><td>0.764</td><td>1.571</td></tr><tr><td colspan="5"> Ramachandran statistics</td></tr><tr><td>  Favored (%)</td><td>91</td><td>98.58</td><td>98.2</td><td>97.11</td></tr><tr><td>  Disallowed (%)</td><td>2.4</td><td>0.0</td><td>0.0</td><td>0.18</td></tr><tr><td>  MolProbity clash score</td><td>9.6</td><td>2.8</td><td>5.16</td><td>2.66</td></tr></tbody></table><table-wrap-foot><fn><p>The CC<sub>1/2</sub> values for the PH-TH-kinase dataset, IP<sub>6</sub>-bound PH-TH dataset and the kinase domain with mutations in the activation loop dataset are 99.9 (86.5), 99.9 (55.4) and 99.9 (90.7), respectively.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl2" position="float"><object-id pub-id-type="doi">10.7554/eLife.06074.006</object-id><label>Table 2.</label><caption><p>Data statistics for the Src-like module of Btk</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.06074.006">http://dx.doi.org/10.7554/eLife.06074.006</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th colspan="4">Src-like module of mouse Btk (217-659)</th></tr></thead><tbody><tr><td colspan="5">Data collection</td></tr><tr><td/><td>KAu(CN)<sub>2</sub></td><td>DMA</td><td>Au2(NO<sub>3</sub>)<sub>3</sub></td><td>native</td></tr><tr><td> Wavelength (Å)</td><td>0.9474</td><td>0.9474</td><td>0.9474</td><td>0.9474</td></tr><tr><td> Space group</td><td>P3<sub>1</sub> 2 1</td><td>P3<sub>1</sub> 2 1</td><td>P3<sub>1</sub> 2 1</td><td>P3<sub>1</sub> 2 1</td></tr><tr><td> <italic>a</italic>,<italic>b</italic>,<italic>c</italic> (Å)</td><td>132.2, 132.2, 107.6</td><td>132.5, 132.5, 107.3</td><td>131.9, 131.9, 107.6</td><td>131.8, 131.8, 107.0</td></tr><tr><td> α,β,γ (°)</td><td>90.0, 90.0, 120.0</td><td>90.0, 90.0, 120.0</td><td>90.0, 90.0, 120.0</td><td>90.0, 90.0, 120.0</td></tr><tr><td> Resolution (Å)</td><td>43.2–2.6</td><td>41.7–3.5</td><td>41.7–3.4</td><td>40–4.0</td></tr><tr><td> <italic>R</italic><sub>sym</sub> (%)</td><td>8.7(&gt;100)</td><td>8.7 (32.7)</td><td>7.5 (32.5)</td><td>5.1 (71.7)</td></tr><tr><td> <italic>I</italic>/σ(<italic>I</italic>)</td><td>10.6 (1.1)</td><td>9.7 (3.0)</td><td>12.1 (3.6)</td><td>18.4 (12.3)</td></tr><tr><td> Completeness (%)</td><td>91.9 (69.6)</td><td>92.4 (94.2)</td><td>94.5 (95.9)</td><td>92.3 (100)</td></tr><tr><td> Redundancy</td><td>4.8 (3.5)</td><td>4.3</td><td>4.1</td><td>N/A</td></tr><tr><td> Wilson B factor</td><td>72.8</td><td>58.8</td><td>70.8</td><td>67.3</td></tr></tbody></table></table-wrap></p></sec><sec id="s2-2"><title>Crystal structure of the Btk SH3-SH2-kinase module</title><p>We determined the structure of a construct of mouse Btk spanning residues 214 to 659, which starts just before the SH3 domain and ends at the C terminus of full-length Btk. The structure resembles those described previously for autoinhibited, Src-like, non-receptor tyrosine kinases, with the SH2-kinase linker sandwiched between the SH3 domain and the small domain of the kinase (the N lobe of the kinase) (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). The crystal structure has two molecules of Btk in the asymmetric unit, intertwined as a domain-swapped dimer in which each SH2 domain has pieces from two molecules (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). The domain-swapped SH2 domain packs against the large domain of the kinase (the C lobe of the kinase), but Btk lacks a Src-like C-terminal tail to stabilize this interaction.</p><p>The sequence identity between Btk and c-Abl is 42%, 31%, and 46% in the SH3, SH2, and kinase domains, respectively; for Btk and c-Src, it is 44%, 29%, and 40%. Superposition of the C lobes of the Btk and c-Abl kinase domains gives an approximately 20° relative rotation of their SH3 domains; superposition of the SH3 domains, a relative rotation of about 15° for their SH2 domains. Similar results are obtained for a comparison to c-Src. Coupling between the SH3 and SH2 domains may therefore be somewhat different in these kinases (<xref ref-type="fig" rid="fig1">Figure 1C</xref>).</p><p>The structure of the SH3 domain of Btk is nearly identical to those determined previously using NMR (the r.m.s. deviation for 53 Cα atoms is 0.9 Å) (<xref ref-type="bibr" rid="bib26">Hansson et al., 1998</xref>; <xref ref-type="bibr" rid="bib69">Tzeng et al., 2000</xref>), except for the expected differences seen at the N and C termini. When compared with the other autoinhibited SH3-SH2-kinase structures (c-Src, Hck, c-Abl), the conserved features of the SH3/linker interaction in Btk are the polyproline type-II helix conformation adopted by residues 383–387 in the SH2-kinase linker, including the proline at position 385, and the overall hydrophobic character of the peptide-binding pocket on the SH3 domain (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). The tryptophan sidechain in the center of this pocket donates a hydrogen bond to a backbone carbonyl of the linker, as in most other SH3-ligand complexes. A cluster of hydrophobic sidechains extends from the binding pocket and the SH3 ‘RT loop’, across the SH2-kinase linker segment, to the β2-β3 loop and strand β4 of the kinase (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Binding of exogenous protein ligands to the Btk SH3 domain would disassemble the Src-like inactive conformation, as seen for the Src family kinase Hck (<xref ref-type="bibr" rid="bib47">Moarefi et al., 1997</xref>).</p><p>Diffuse electron density for the SH2 domain at every stage of our structure determination shows that this part of the polypeptide chain occupies a range of positions and adopts multiple local conformations. The domain itself has a marginally stable internal structure, as shown by the domain swap, and it is probably imperfectly locked in place. The SH2 βA/αA loop lies between kinase-domain helices αB and αF. Density features for this loop are relatively sharp, and the rest of the domain may pivot somewhat about its contact with the C lobe.</p><p>The domain swap occurs in the same location within the SH2 domain as a domain swap seen in a Grb2 SH2-domain crystal structure (<xref ref-type="bibr" rid="bib59">Schiering et al., 2000</xref>). The SH2 domain opens up at a position within the subsidiary β-sheet, so that helix B of one polypeptide chain packs against the main β-sheet of the other and vice versa (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). This exchange occurs in solution for Btk, as only the dimeric species crystallizes. The similar domain swap seen in two SH2 domains not closely related in their specificity or functions suggest that other SH2 domains may also have the same bipartite character.</p><p>There is no evidence that a domain-swapped dimer (or, indeed, any stable dimer) is a functional state of intact Btk, and so it is likely that the assembled state involves a single polypeptide chain, rather than two inter-folded chains. The relatively high concentration of purified protein could have promoted dimer formation in our preparations. In the case of Grb2, the structure of the intact protein, a monomer in solution, shows no domain swap, and loss of contacts between the deleted N- and C-terminal SH3 domains can account for destabilization of the central SH2 when it is prepared as an isolated domain (<xref ref-type="bibr" rid="bib43">Maignan et al., 1995</xref>). For Btk, the PH-TH module might stabilize the Src-like module.</p><p>The unphosphorylated activation loop of Btk folds into the mouth of the catalytic cleft, blocking part of the substrate-binding site, and helix αC lies at the margin of the N lobe, preventing formation of a Glu-Lys salt bridge conserved in all catalytically active protein kinases (<xref ref-type="bibr" rid="bib66">Taylor and Kornev, 2011</xref>) (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). The activation loop of Btk is in a conformation seen in the structure of a Btk kinase domain-inhibitor complex (PDB: 3OCS; [<xref ref-type="bibr" rid="bib18">Di Paolo et al., 2011</xref>]), and in autoinhibited c-Src (the r.m.s. deviation from c-Src is 2.3 Å for the 24 α-carbons of the activation loop), but the cleft between the two lobes of the kinase is substantially more open in Btk than in c-Src. Helix αC is also displaced from the catalytic cleft, as in inactive c-Src or cyclin-dependent kinases. The segment of the activation loop that contacts the N lobe shifts with it, with respect to c-Src as a reference, by up to 3 Å, away from the C lobe.</p><p>A network of polar interactions present in the autoinhibited forms of c-Src and Hck is also present in the Btk conformation in our crystals (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>). Glu 445, which would buttress Lys 430 in the active conformation, interacts instead with Arg 544 and Tyr 545. Arg 544 stacks in turn on Arg 520, clamping the latter against the phenyl ring of Phe 574. Each of these arginines also appears to have an amino–aromatic interaction: Arg 544 with Phe 517 and Arg 520 with Phe 574. In the active conformation of Btk, the same two arginines are expected (based on the structure of the active Lck kinase domain, PDB: 3LCK; [<xref ref-type="bibr" rid="bib77">Yamaguchi and Hendrickson, 1996</xref>]) to engage in salt bridges with a phosphorylated Tyr 551. Activation thus entails a shuffling of salt-bridge and polar hydrogen-bond partners, described in the case of Src kinases as an ‘electrostatic switch’ (<xref ref-type="bibr" rid="bib53">Ozkirimli and Post, 2006</xref>; <xref ref-type="bibr" rid="bib3">Banavali and Roux, 2009</xref>) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>). In addition, the inactive conformation is stabilized by interactions made by the SH2-kinase linker. Leu 390 of the linker (corresponding to Trp 260 in c-Src) is sandwiched between residues Trp 421 and Tyr 461 in the kinase domain (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). The hydrophobic packing between Trp 421 and Leu 390 would not be possible in the active conformation of the kinase domain.</p><p>The structure just described demonstrates that the SH3-SH2 domain in a Tec-family member can assemble into a regulatory clamp, just as it does in other Src-like kinases. In the crystal structures of c-Src, Hck, and c-Abl, a latch is present—either in the form of a phosphorylated C-terminal tail (c-Src, Hck) or a myristoyl group bound in a pocket on the C lobe of the kinase domain (c-Abl). In both cases, the latch secures the SH2-domain/C lobe contact, precisely the interface that appears to be poorly formed in our Btk crystals. As we show below, the latch in Btk is provided by the PH-TH module.</p></sec><sec id="s2-3"><title>Structure of a PH-TH-kinase construct of Btk</title><p>We expressed a ‘PH-TH-kinase’ construct of bovine Btk that contains the PH-TH module connected to the kinase domain by the 13-residue SH2-kinase linker. We replaced six residues in the activation loop of Btk with the corresponding ones in Itk, shown previously to stabilize the activation loop of the Btk kinase domain (<xref ref-type="bibr" rid="bib34">Joseph et al., 2013</xref>). This improved the poorly ordered crystals obtained with the unmutated form, leading to a structure of the PH-TH-kinase with a bound ATP-competitive inhibitor (CGI1746, [<xref ref-type="bibr" rid="bib18">Di Paolo et al., 2011</xref>]) at 1.7 Å resolution (<xref ref-type="fig" rid="fig2">Figure 2A</xref>).<fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.06074.007</object-id><label>Figure 2.</label><caption><title>Crystal structure of the PH-TH-kinase construct of Btk.</title><p>(<bold>A</bold>) Crystal structure of the PH-TH-kinase construct. The PH-TH module is connected to the kinase domain via a 13-residue linker from the SH2-kinase linker of Btk. The kinase domain is bound to the inhibitor CGI1746 (<xref ref-type="bibr" rid="bib18">Di Paolo et al., 2011</xref>). The canonical PIP<sub>3</sub>/IP<sub>4</sub> binding pocket of the PH domain is located distal to the interface with the kinase, and the peripheral binding site for IP<sub>6</sub> is indicated. (<bold>B</bold>) The interface between the PH-TH module and the kinase domain of Btk.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.06074.007">http://dx.doi.org/10.7554/eLife.06074.007</ext-link></p></caption><graphic xlink:href="elife-06074-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.06074.008</object-id><label>Figure 2—figure supplement 1.</label><caption><title>Structure of the kinase domain of Btk and its interaction with the PH domain.</title><p>(<bold>A</bold>) Crystal structure of the isolated Btk kinase domain with mutations in the activation loop. These mutations (L542M, S543T, V555T, R562K, S564A, and P565S) are based on a previous study (<xref ref-type="bibr" rid="bib34">Joseph et al., 2013</xref>), and they improved the quality of the crystals of the PH-TH-kinase construct. The structure of the mutant kinase is very similar to that of the wild-type Btk kinase domain (PDB: 3OCS). (<bold>B</bold>) Comparison of the Btk PH-TH-kinase structure (left) and the Akt1 PH-kinase structure (right). In Akt1, The PH domain is docked between the N lobe and the C lobe of the kinase domain, and it blocks substrate access to the catalytic cleft. The lipid-binding site on the PH domain is buried at the PH-kinase interface, and binding of PIP<sub>3</sub>/IP<sub>4</sub> breaks the PH-kinase interface and activates Akt1 (<xref ref-type="bibr" rid="bib75">Wu et al., 2010</xref>; <xref ref-type="bibr" rid="bib11">Calleja et al., 2009</xref>).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.06074.008">http://dx.doi.org/10.7554/eLife.06074.008</ext-link></p></caption><graphic xlink:href="elife-06074-fig2-figsupp1-v2.tif"/></fig></fig-group></p><p>The overall conformation of the kinase domain, as well as the specific conformation of the activation loop, is very similar in the two structures we have determined (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). We also determined the structure of the isolated Btk kinase domain with the six mutations described above and found by comparing it to wild-type Btk that the mutations do not introduce major perturbations in the structure (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). Details of expression, purification, crystallization, and structure determination are in the ‘Materials and methods’.</p><p>The PH-TH module contacts the kinase N lobe. The interface differs substantially from the one found in Akt1, another PH-domain regulated kinase (<xref ref-type="bibr" rid="bib75">Wu et al., 2010</xref>) (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). In Akt1, the PH domain sits in front of the catalytic cleft of the kinase, blocking peptide substrate binding. In Btk, the PH-kinase interface does not directly occlude the active site. The interface combines a set of hydrophobic contacts with a hydrogen-bond network (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). In particular, Tyr 134 at the C terminus of helix α2 of the PH-TH packs into a groove between Trp 395 at the linker-kinase junction and helix αC in the kinase N lobe. We expect these interactions to stabilize the inactive conformation of the kinase, by hindering the shift in helix αC that accompanies kinase activation. Experiments confirming these expectations are described below, in the section on ‘Autoinhibition’.</p></sec><sec id="s2-4"><title>A structural model for full-length Btk</title><p>We combined the two structures just described to build a model for full-length Btk (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Aligning the kinase domains in the two structures gives some local overlap between helix α2 in the PH-TH module and the β3/β4 loop in the SH3 domain, but otherwise compatible positions for the regulatory domains (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). We therefore carried out molecular dynamics simulations of the two component structures and of the composite assembly, to determine whether energetically minor adjustments could resolve the remaining clashes. The trajectories ranged in length from 60 to 150 ns (see ‘Materials and methods’ for computational details).<fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.06074.009</object-id><label>Figure 3.</label><caption><title>A structural model for full-length Btk.</title><p>(<bold>A</bold>) A composite model for full-length Btk. The PH-TH domain sits on top of the kinase domain and the SH3 domain, serving as a ‘latch’ that presumably stabilizes the Src-like module in the autoinhibited conformation. The 45-residue linker between the PH-TH module and the SH3 domain is represented by the dotted brown line. Two orthogonal views of an instantaneous structure at 360 ns from a molecular dynamics trajectory for the composite model are shown. (<bold>B</bold>) Inter-domain interactions in an instantaneous structure at 360 ns from a simulation of the composite model. The SH2/kinase interface and the PH-TH /SH3 interface are formed and remain stable during the molecular dynamics simulation.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.06074.009">http://dx.doi.org/10.7554/eLife.06074.009</ext-link></p><p><supplementary-material id="SD2-data"><object-id pub-id-type="doi">10.7554/eLife.06074.010</object-id><label>Figure 3—source data 1.</label><caption><title>Structures from several time points in the simulation of the composite model for full-length Btk.</title><p>The structures are taken every 20 ns from a 360 ns molecule dynamic simulation of the composite model. See ‘Materials and methods’ for the details of simulations.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.06074.010">http://dx.doi.org/10.7554/eLife.06074.010</ext-link></p></caption><media mime-subtype="pdb" mimetype="chemical" xlink:href="elife-06074-fig3-data1-v2.pdb"/></supplementary-material></p></caption><graphic xlink:href="elife-06074-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.06074.011</object-id><label>Figure 3—figure supplement 1.</label><caption><title>Utilization of molecular dynamics in constructing a model for full-length Btk.</title><p>(<bold>A</bold>) Overlay of the crystal structures of the Btk Src-like module and the PH-TH-kinase construct, using the kinase domain C lobe as the reference. Sidechain clashes (circled) are observed between helix α2 in the PH-TH module and the β3/β4 loop segment in the SH3 domain. (<bold>B</bold>) Fluctuations in the Btk Src-like module occurred during a 100 ns molecular dynamics simulation. An instantaneous structure (t = 89 ns) from the simulation is overlaid on the crystal structure of the Src-like module. (<bold>C</bold>) Fluctuations in the Btk PH-TH-kinase construct during a 100 ns molecular dynamics simulation. An instantaneous structure (t = 12 ns) from the simulation is overlaid on the crystal structure of the PH-TH-kinase construct using the kinase domain N lobe as the reference. The PH-TH module pivots (black arrow) about an apparent anchor point at the C terminus of helix α2. (<bold>D</bold>) Steps used to generate a composite model for full-length Btk. An instantaneous structure (t = 89 ns) of the Src-like module and an instantaneous structure (t = 12 ns) of the PH-TH-kinase construct from the molecular dynamics trajectory are overlaid, using the kinase domain C-lobe as the reference. In contrast to a corresponding overlay of the crystal structures, there are no sidechain clashes between helix α2 in the PH-TH module and the loop in the SH3 domain. A model for full-length Btk is obtained by combining the PH-TH module with the Src-like module in the two instantaneous structures, and is subject to further molecular dynamics simulation.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.06074.011">http://dx.doi.org/10.7554/eLife.06074.011</ext-link></p></caption><graphic xlink:href="elife-06074-fig3-figsupp1-v2.tif"/></fig></fig-group></p><p>In simulations of the SH3-SH2-kinase module, the initial and final conformations of the SH3 and kinase domains had r.m.s. deviations in Cα positions of only ∼3.0 and ∼2.0 Å, respectively, after first aligning the C lobe of the kinase domain (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>). The SH2 domain shifted by ∼6 Å, with a roughly 10° rotation that brought it closer to the C lobe of the kinase domain and closer to its position in the inactive forms of c-Src, Hck, and c-Abl. Some adjustment of the SH2 domain in these simulations was expected, as the domain swap in the crystals probably perturbed the domain to some extent, and the starting structure for the simulations was therefore itself an approximation.</p><p>In simulations of the PH-TH-kinase construct, the interface with the kinase domain remained intact, but the PH-TH module wobbled back and forth through a rotation of about 20° (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>). The averaged r.m.s. deviation between the crystal structure and structures from the end of the trajectories, aligned on the kinase domain, was ∼4 Å for the PH-TH module. The PH-TH module pivots about an apparent anchor point at the C terminus of helix α2, at the center of the autoinhibitory contact (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>).</p><p>The fluctuations in the PH-TH orientation generate transient structures in which there would be essentially no clashes between the SH3 domain and the PH-TH module in the merged structures. We initiated multiple MD trajectories from such a composite model (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). The inhibitory interactions between each of the regulatory modules and the kinase domain were preserved, but various intra-domain rearrangements occurred during the course of these trajectories. The overall conformation of Btk at the end of the trajectories is very similar to the initial structure. The averaged r.m.s. deviations of the PH-TH module and the SH3 domain between the crystal structures and the end of trajectories, aligned on the Src-like module of the kinase, were ∼4 Å and ∼2.5 Å, respectively. The former is comparable to the value found in simulations of the PH-TH-kinase, but the latter is larger than in simulations of the Src-like module, probably because the SH3 domain reorients with respect to the kinase domain. The SH3 rotation results in a polar interface between SH3 and PH-TH, with good electrostatic complementarity, which preserves the interactions between the SH3 domain, the linker and the N lobe of the kinase (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). In these simulations, the r.m.s. deviations of the SH2 domain and the kinase N lobe are ∼2.6 Å and 2.0 Å, respectively, after 360 ns, similar to those of the Src-like module simulations. We emphasize, however, that restrictions in the time scale of the simulations allow only qualitative conclusions and do not give a high-resolution picture of the intact molecule. Structures from several time points in the simulation of the composite model are deposited on the <italic>eLife</italic> website (<xref ref-type="supplementary-material" rid="SD2-data">Figure 3—source data 1</xref>).<fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.06074.012</object-id><label>Figure 4.</label><caption><title>Autoinhibition of Btk.</title><p>(<bold>A</bold>) Activation of full-length bovine Btk (residues 1 to 659, 2 μM). Reactions are carried out in the presence of 10 mM Mg<sup>2+</sup>, 150 mM NaCl, 1 mM ATP, 25 mM Tris-HCl pH 8.0. The level of autophosphorylation is assayed by immunoblotting an SDS-PAGE gel with a non-specific, anti-phosphotyrosine antibody (4G10, EMD Millipore) (upper panel). The amount of total protein loaded on the gel is measured by coomassie-blue staining. The kinase activity of Btk is assayed by a continuous kinase-coupled colorimetric assay, in the presence of 1 mM PLC-γ2 peptide substrate. See methods for detailed experimental procedures. (<bold>B</bold>) Comparison of the activation of the Btk Src-like module (residues 217 to 659), SH2-kinase (residues 270 to 659), and the kinase domain (residues 394 to 659). The SH2-kinase construct activates substantially faster than full-length Btk and the Src-like module of Btk. Activated full-length Btk degrades to a small extent over time, which results in some lower molecule-weight bands being detected on the western blot. (<bold>C</bold>) Activation of full-length Btk with mutations Y223A and Y268A. Tyr 223 and Tyr 268 are on the SH3/SH2-linker interface, and the two mutants activate faster than wild-type Btk. (<bold>D</bold>) Activation of full-length Btk with a double mutation (R134E/Y133E). Arg 134 and Tyr 133 are located at the PH-TH/kinase interface.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.06074.012">http://dx.doi.org/10.7554/eLife.06074.012</ext-link></p></caption><graphic xlink:href="elife-06074-fig4-v2.tif"/></fig></p></sec><sec id="s2-5"><title>Autoinhibition</title><p>We probed the significance of the interactions seen in the crystal structures by studying how various mutations affect the rate of autophosphorylation and enzymatic activity. We avoided the heterogenous phosphorylation that accompanies expression in eukaryotic cells by using bovine Btk expressed in bacteria, which gives a pure, unphosphorylated product with good yield. Bovine Btk is 98.8% identical to human Btk in sequence, with only eight amino-acid differences over the entire protein. The mass of the bacterially expressed full-length Btk (76,379 Da), as determined by mass spectrometry, is consistent with the calculated molecular weight (76,381.2 Da).</p><p>Incubation with ATP-Mg<sup>2+</sup> initiates autophosphorylation, leading in turn to increased catalytic activity. We monitored activation in two ways. First, we monitored the phosphorylation by Btk of a peptide substrate derived from PLC-γ2, using a continuous kinase-coupled colorimetric assay (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Second, we followed accumulation of tyrosine-phosphorylated Btk by immunoblotting with a non-specific, anti-phosphotyrosine antibody (4G10, EMD Millipore) (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). The results of the two assays are in good agreement.</p><p>The kinase domain of Btk has low catalytic activity and autophosphorylates very slowly, like the c-Abl kinase domain and unlike those of the Src family (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). For example, there is no detectable change over 90 min in the level of phosphorylation of the Btk kinase domain at 4 μM concentration. Inclusion of the SH2 domain and the SH2-kinase linker (but not the SH3 domain or the PH-TH module) increases Btk autophosphorylation substantially (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). We have not studied how the SH2 domain increases activity, but we note that in c-Abl, the SH2 domain docks onto the N lobe of the kinase domain and stabilizes the active conformation and that activation by the SH2 domain is also seen in Csk (<xref ref-type="bibr" rid="bib63">Sondhi and Cole, 1999</xref>) and c-Fes (<xref ref-type="bibr" rid="bib51">Nagar et al., 2006</xref>; <xref ref-type="bibr" rid="bib24">Filippakopoulos et al., 2008</xref>). The apparent linear array of domains detected by small-angle x-ray scattering from a partially phosphorylated form of full-length Btk might represent the activated rather than the inactive form, in a conformation similar to that of activated c-Abl (<xref ref-type="bibr" rid="bib44">Márquez et al., 2003</xref>; <xref ref-type="bibr" rid="bib51">Nagar et al., 2006</xref>).</p><p>The autoactivation rate of the complete Src-like module of Btk is lower than that of the SH2-kinase module (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), as expected from the joint clamping effect of the SH3 and SH2 domains. Based on contacts seen in the crystal structure of the Src-like module of Btk, we introduced (separately) two mutations, Y223A and Y268A, into full-length Btk. These SH3-domain residues pack against Pro 385 in the SH2-kinase linker, and their phosphorylation (or mutation to alanine) would destabilize the autoinhibited conformation (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). The autoactivation rates of both mutants are indeed about sixfold greater than that of the unmutated enzyme and comparable to that of the SH2-kinase module (the rate of activation is estimated from the slope of activity vs time, and is only a rough measure because of non-linearity; <xref ref-type="fig" rid="fig4">Figure 4C</xref>). An analogous interaction regulates c-Abl activation: phosphorylation of Tyr 89, in the SH3-kinase interface, is necessary for full activation (<xref ref-type="bibr" rid="bib7">Brasher and Van Etten, 2000</xref>).</p><p>Mutations expected to disrupt the PH-TH-kinase interface likewise increase the autoactivation rate of full-length Btk, consistent with our inferences from examining the interface between the PH-TH and the kinase N lobe (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Removal of the entire PH-TH module, while retaining the Src-like regulatory components, increases the rate of autoactivation about threefold, as estimated from the slopes of the activity curves in <xref ref-type="fig" rid="fig4">Figure 4</xref>.</p></sec><sec id="s2-6"><title>Activation of Btk by membrane recruitment</title><p>We studied the effect on Btk activity of PIP<sub>3</sub> in small unilamellar vesicles (SUVs). SUVs containing 75% DOPC, 20% DOPS, and 5% PIP<sub>3</sub> produce a rapid and substantial activation of Btk (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). At a Btk concentration of 2 μM, robust phosphorylation can be detected within the first 5 min of reaction in the presence of these vesicles. The extent of activation depends on the concentration of PIP<sub>3</sub> in the vesicles, presumably because increasing the PIP<sub>3</sub> fraction increases the surface density of Btk on the lipid vesicles and thereby increases the rate of trans-autophosphorylation (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). An estimate of the surface density of PIP<sub>3</sub> on these vesicles suggests that the local concentration of Btk on the vesicle surface is in the millimolar range, that is, 100-fold greater than in bulk solution (see ‘Materials and methods’ for detailed calculations).<fig-group><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.06074.013</object-id><label>Figure 5.</label><caption><title>Activation of Btk.</title><p>(<bold>A</bold>) Activation of full-length Btk on membranes. Left panel: Btk (1 μM) autophosphorylates rapidly on lipid vesicles (total lipid concentration, 1 mM) containing 75% DOPC, 20% DOPS and 5% PIP<sub>3</sub>. Right panel: end-point autophosphorylation assay of Btk in the presence of lipid vesicles. The molar concentration of DOPC is kept at 75%, and the lipid fractions of PIP<sub>3</sub> is 0%, 2%, 5%, and 10%, with the remaining lipid fraction filled with DOPS. The measurements are performed after 2 min incubation with lipid vesicles in the presence of ATP/Mg<sup>2+</sup>. (<bold>B</bold>) End-point autophosphorylation assays of Btk in solution in the presence of inositol phosphates. Upper panel: Btk (2 μM) autophosphorylates rapidly in the presence of 100 μM IP<sub>6</sub> in solution, with the results after the first 5 min of incubation shown here. Essentially no phosphorylation is detected in Btk samples incubated with IP<sub>3</sub>, IP<sub>4</sub> or I(1,3,4,5,6)P<sub>5</sub>, and very low phosphorylation is detected in Btk samples incubated with I(1,2,3,5,6)IP<sub>5</sub> and I(2,3,4,5,6)IP<sub>5</sub> in the same experiment. Lower panel: the assay is repeated with other inositol phosphates at a higher protein concentration (4 μM) and longer incubation time (10 min), and the gel was exposed for a longer time. There is a small amount of degraded Btk in the sample, as judged by the coomassie staining, leading to multiple bands in the western blot shown here and in panel <bold>C</bold>. (<bold>C</bold>) Activation of full-length Btk (2 μM) in the presence of IP<sub>6</sub> (100 μM). (<bold>D</bold>) Activation of full-length Btk (2 μM) with increasing concentrations of IP<sub>6</sub>.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.06074.013">http://dx.doi.org/10.7554/eLife.06074.013</ext-link></p></caption><graphic xlink:href="elife-06074-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.06074.014</object-id><label>Figure 5—figure supplement 1.</label><caption><title>Activation of various deletion constructs of Btk.</title><p>(<bold>A</bold>) End-point autophosphorylation assay for full-length Btk, the Src-like module, the SH2-kinase construct and the kinase domain in the presence/absence of IP6. The measurements are carried out after incubating proteins (2 μM) with and without IP<sub>6</sub> (100 μM) for 2 min in the presence of ATP/Mg<sup>2+</sup>. (<bold>B</bold>) End-point autophosphorylation assay for Btk PH-TH-kinase constructs of various linker lengths in the presence/absence of IP<sub>6</sub> (100 μM). The measurements are carried out after incubating proteins (2 μM) with and without IP<sub>6</sub> (100 μM) for 2 min at the presence of ATP/Mg<sup>2+</sup>. (<bold>C</bold>) Activation of the PH-TH-kinase construct (2 μM) with a 13-residue linker in the presence and absence of IP<sub>6</sub> (100 μM). (<bold>D</bold>) Activation of full-length Btk (2 μM) with mutations R133E/Y134E in the presence and absence of IP<sub>6</sub> (100 μM). Arg 133 and Tyr 134 are located at the PH-TH/kinase interface.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.06074.014">http://dx.doi.org/10.7554/eLife.06074.014</ext-link></p></caption><graphic xlink:href="elife-06074-fig5-figsupp1-v2.tif"/></fig></fig-group></p><p>We next studied the effect of inositol phosphates, the soluble headgroups of various phosphatidylinositol phosphate lipids, on Btk activity. The purpose of these studies was to see whether interactions with the soluble headgroups might activate Btk independent of membrane localization, as is the case with Akt (<xref ref-type="bibr" rid="bib11">Calleja et al., 2009</xref>; <xref ref-type="bibr" rid="bib75">Wu et al., 2010</xref>). The soluble headgroup of PIP<sub>3</sub> is IP<sub>4,</sub> and so this was included in our study, as were several other inositol phosphates (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). IP<sub>4</sub> itself has no effect on the rate of Btk activation in solution, demonstrating that the role of PIP<sub>3</sub> is to recruit Btk to the membrane without necessarily triggering an allosteric effect.</p></sec><sec id="s2-7"><title>Activation of Btk by IP<sub>6</sub> in solution</title><p>We tested the effect of 10 other inositol phosphates on the activity of Btk (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Quite unexpectedly, we discovered that inositol hexakisphosphate (IP<sub>6</sub>) promotes Btk autophosphorylation strongly at 2 μM protein concentration, substantially enhancing Btk catalytic activity within the first 5 min after addition (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). We also saw a milder activation with certain inositol pentakisphosphates (IP<sub>5</sub>), but these required higher protein concentration and longer times for appreciable autophosphorylation than did IP<sub>6</sub> (<xref ref-type="fig" rid="fig5">Figure 5B</xref>).</p><p>The EC<sub>50</sub> value for IP<sub>6</sub> activation is around 20 μM (<xref ref-type="fig" rid="fig5">Figure 5D</xref>), in the range of the physiological concentration of IP<sub>6</sub> in cells, which is 10 μM–80 μM (<xref ref-type="bibr" rid="bib31">Irvine and Schell, 2001</xref>; <xref ref-type="bibr" rid="bib61">Shears, 2001</xref>). In the presence of a saturating concentration of IP<sub>6</sub> (100 μM), full-length Btk is activated within the first 5 min of reaction time, in contrast to the 30 min and 120 min that are required for the activation of the SH2-kinase module and full-length Btk, respectively, in the absence of IP<sub>6</sub> or PIP<sub>3</sub>-containing vesicles (<xref ref-type="fig" rid="fig5">Figure 5A,C</xref>). Once fully activated, the catalytic rates of various Btk constructs are the same with or without IP<sub>6</sub> addition, suggesting that the effect of IP<sub>6</sub> is to change the rate of autophosphorylation, and that it does not affect the catalytic machinery directly (<xref ref-type="fig" rid="fig5">Figure 5C</xref>).</p><p>By comparing constructs, we determined which domains in Btk are responsible for the IP<sub>6</sub> response. Activation by IP<sub>6</sub> required only the PH-TH module and not the SH3 and SH2 domains (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A,B</xref>). A PH-TH-kinase construct that contained the PH-TH-SH3 linker and the SH2-kinase linker (with a total linker length of 45 residues) had the same response to IP<sub>6</sub> as did full-length Btk (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>). PH-TH-kinase constructs with shorter linkers also responded to IP<sub>6</sub>. The shortest linker necessary for activation contained only 13 residues from the SH2-kinase linker; we used this construct to determine the crystal structure described earlier (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>). The catalytic activity of the fully activated PH-TH-kinase construct was about threefold lower than that of full-length Btk. This lower activity can be explained by the absence of the SH2 domain.</p><p>IP<sub>6</sub> has no effect on activation of the isolated kinase domain of Btk, suggesting that it is not a direct allosteric activator of the enzyme. The protein kinase CK2 is activated by IP<sub>6</sub>, which binds to the kinase domain and dislodges an inhibitory interaction between CK2 and the protein Nopp140 (<xref ref-type="bibr" rid="bib39">Lee et al., 2013</xref>). It seems unlikely that IP<sub>6</sub> works by displacing an inhibitory interaction between the kinase and the PH-TH module, because the Src-like module (lacking the PH-TH module) activates only slightly faster than full-length Btk in the absence of IP<sub>6</sub>. Nevertheless, in order to test this possibility, we introduced two mutations (Y133E and R134E) at the PH-TH-kinase interface that are expected to disrupt the inhibitory docking of the PH-TH module on the kinase domain. Full-length Btk bearing these two mutations retains activation by IP<sub>6</sub>, showing that IP<sub>6</sub> does not act by dislodging the interactions seen in the crystal structure (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>).</p></sec><sec id="s2-8"><title>The canonical lipid-binding pocket of the PH-TH module is not critical for IP<sub>6</sub>-mediated Btk activation</title><p>The structure of the PH-TH-kinase construct does not provide direct clues about how IP<sub>6</sub> might activate Btk. The IP<sub>4</sub>-binding site on the PH-TH module (the ‘canonical binding site’) is located ∼15 Å from the kinase-interacting surface of the PH-TH module (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). The structure of the PH-TH-kinase construct, in which no inositol phosphates are bound, resembles closely that of the liganded PH domain (<xref ref-type="bibr" rid="bib4">Baraldi et al., 1999</xref>) in the vicinity of the PH-kinase interface, consistent with the failure of IP<sub>4</sub> to activate Btk.</p><p>We used isothermal titration calorimetry (ITC) to study the interaction between IP<sub>6</sub> and various constructs of Btk (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). The ITC measurements show that among the four domains in Btk, only the PH-TH module interacts with IP<sub>6</sub>. At 150 mM NaCl concentration, the titration curve for IP<sub>6</sub> binding to the PH-TH module can be fit by a one-site model for binding, with a dissociation constant, K<sub>d</sub>, of 250 nM (<xref ref-type="table" rid="tbl3">Table 3</xref>). We introduced two mutations, R28C and N24E, at the canonical binding site in the PH-TH module. Arg 28 and Asn 24 have been shown previously to be critical for IP<sub>4</sub> binding (<xref ref-type="bibr" rid="bib30">Hyvönen and Saraste, 1997</xref>; <xref ref-type="bibr" rid="bib4">Baraldi et al., 1999</xref>). IP<sub>4</sub> binds to the PH-TH module with a K<sub>d</sub> value of 30 nM, and the R28C/N24E mutation in the PH-TH module reduces IP<sub>4</sub> binding to an undetectable level (<xref ref-type="table" rid="tbl3">Table 3</xref>). The ITC signal of IP<sub>6</sub> binding to the R28C/N24E mutant is reduced greatly but not completely abolished, and the residual signal corresponds to a dissociation constant between 5 μM and 10 μM.<fig id="fig6" position="float"><object-id pub-id-type="doi">10.7554/eLife.06074.015</object-id><label>Figure 6.</label><caption><title>Binding of IP<sub>4</sub> and IP<sub>6</sub> to the Btk PH-TH module.</title><p>(<bold>A</bold>) Representative isothermal titration calorimetry data for the Btk PH-TH module and its R28C/N24D variant binding to IP<sub>4</sub> or IP<sub>6</sub>. The protein concentration is 20 μM and that of the inositol phosphates goes up to 300 μM. Experiments are performed at 20°C. Titration curves are shown with the baseline-corrected raw data. The parameters from fitting a one-site binding model are listed in <xref ref-type="table" rid="tbl3">Table 3</xref>. (<bold>B</bold>) Activation of full-length Btk N24D/R28C mutant (2 μM) in the presence and absence of IP<sub>6</sub> (100 μM). Asn 24 and Arg 28 are critical residues for PIP<sub>3</sub>/IP<sub>4</sub> binding in the canonical lipid-binding pocket of the PH-TH module.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.06074.015">http://dx.doi.org/10.7554/eLife.06074.015</ext-link></p></caption><graphic xlink:href="elife-06074-fig6-v2.tif"/></fig><table-wrap id="tbl3" position="float"><object-id pub-id-type="doi">10.7554/eLife.06074.016</object-id><label>Table 3.</label><caption><p>Thermodynamic parameters for Btk PH-TH module binding to IP<sub>6</sub> and IP<sub>4</sub></p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.06074.016">http://dx.doi.org/10.7554/eLife.06074.016</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th>Protein</th><th>Ligand</th><th>N</th><th>K<sub>a</sub> (×10<sup>6</sup>)</th><th>K<sub>d</sub> (nM)</th><th>ΔH (Kcal/mol)</th><th>ΔS (cal/mol/deg)</th></tr></thead><tbody><tr><td>Wild-type PH-TH</td><td>IP<sub>6</sub></td><td>1.1 ± 0.1</td><td>4.2 ± 0.3</td><td>238 ± 32</td><td>−1.1 ± 0.2</td><td>26.7</td></tr><tr><td>Wild-type PHTH</td><td>IP<sub>4</sub></td><td>0.9 ± 0.1</td><td>39 ± 11</td><td>26 ± 6</td><td>4.4 ± 0.1</td><td>49.5</td></tr><tr><td>PH-TH R28C/D24N</td><td>IP<sub>6</sub></td><td>0.7 ± 0.2</td><td>0.21 ± 0.03</td><td>4760 ± 700</td><td>−1.7 ± 0.6</td><td>17.5</td></tr></tbody></table><table-wrap-foot><fn><p>The integrated heat from representative isothermal titration calorimetry experiments was fit with a one-binding site model. See methods for the details of data analysis.</p></fn></table-wrap-foot></table-wrap></p><p>Although the residual binding of IP<sub>6</sub> to the IP<sub>4</sub>-binding deficient mutant is relatively weak, the observed affinity is consistent with the EC<sub>50</sub> value of 20 μM for IP<sub>6</sub> activation, as determined in our activation assays (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). We observed no significant activation when the IP<sub>6</sub> concentration was lower than 5 μM, a level still high enough to saturate the canonical binding site. We also found that the R28C/N24E mutant that is deficient in IP<sub>4</sub> binding remains highly responsive to IP<sub>6</sub> stimulation, with only a slight reduction in the activation kinetics as compared to the wild-type protein (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). These observations imply that the canonical binding site of the PH-TH module may not play a major role in the IP<sub>6</sub>-mediated activation of Btk.</p></sec><sec id="s2-9"><title>Structure of the IP<sub>6</sub>-bound PH-TH module</title><p>We determined a crystal structure of the Btk PH-TH module bound to IP<sub>6</sub> at 2.3 Å (<xref ref-type="fig" rid="fig7">Figure 7</xref>). There are four PH-TH modules in the asymmetric unit of the crystal, which form two dimers, similar to those seen in other structures of the Btk PH-TH module (<xref ref-type="fig" rid="fig7">Figure 7D</xref>) (<xref ref-type="bibr" rid="bib30">Hyvönen and Saraste, 1997</xref>; <xref ref-type="bibr" rid="bib4">Baraldi et al., 1999</xref>). The only structural changes in the IP<sub>6</sub>-bound PH-TH module, relative to the apo- or IP<sub>4</sub>-bound PH-TH module, are in the loop regions (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1B</xref>).<fig-group><fig id="fig7" position="float"><object-id pub-id-type="doi">10.7554/eLife.06074.018</object-id><label>Figure 7.</label><caption><title>Crystal structure of the PH-TH module bound to IP<sub>6.</sub></title><p>(<bold>A</bold>) Structure of the PH-TH module bound to two IP<sub>6</sub> molecules. One IP<sub>6</sub> molecule is in the canonical lipid-binding site and the other IP<sub>6</sub> molecule is in the peripheral binding site formed by strands β3 and β4. The β1/β2 loop (dotted lines) is disordered in this structure. (<bold>B</bold>) IP<sub>6</sub> coordination in the canonical binding site and in the peripheral binding site. (<bold>C</bold>) Activation of the Btk R52S/K49S mutant (2 μM) in the presence and absence of IP<sub>6</sub> (100 μM). Arg 52 and Lys 49 are two residues interacting with IP<sub>6</sub> in the peripheral binding site. (<bold>D</bold>) A dimer assembly of the Btk PH-TH module in the crystal structure of the IP<sub>6</sub>-bound PH-TH module. The canonical binding site and the peripheral binding site are shown in blue and magenta circle, respectively. We refer to this dimer as the ‘Saraste dimer’ (<xref ref-type="bibr" rid="bib30">Hyvönen and Saraste, 1997</xref>). (<bold>E</bold>) An electron density map, using σ<sub>A</sub>-weighted 2m|F<sub>o</sub>| − D|F<sub>c</sub>| coefficients (<xref ref-type="bibr" rid="bib57">Read, 1986</xref>) for IP<sub>6</sub> at the peripheral binding site, contoured at 1.5 σ.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.06074.018">http://dx.doi.org/10.7554/eLife.06074.018</ext-link></p></caption><graphic xlink:href="elife-06074-fig7-v2.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.06074.019</object-id><label>Figure 7—figure supplement 1.</label><caption><title>Aspects of the binding of IP<sub>6</sub> to Btk.</title><p>(<bold>A</bold>) An open-ended chain of PH-TH dimers in the crystal lattice, mediated by IP6 at the pheripheral site. IP<sub>6</sub> is bound at the peripheral site in such a way that only one IP<sub>6</sub> molecule occupies the two sites at each interface. (<bold>B</bold>) Structure superposition of the IP<sub>6</sub>-bound PH-TH module with apo- and the IP<sub>4</sub>-bound PH-TH module. The β1/β2 loop, which coordinates IP<sub>4</sub> binding, adopts a different conformation in the apo-structure, and is partially disordered in the IP<sub>6</sub>-bound structure. (<bold>C</bold>) IP<sub>6</sub> coordination in the peripheral binding site by a crystal symmetry mate of the PH-TH module in the crystal structure of IP<sub>6</sub>-bound PH-TH module. IP<sub>6</sub> and the residues involved in coordination are shown in sticks. The hydrogen bonds are shown in dotted lines. This is a detailed view of the interfacial sites shown in the schematic diagram in Panel <bold>A</bold>. (<bold>D</bold>) Isothermal titration calorimetry data for Btk PH-TH mutant R52E/K49E/R28C/N24D titrated with IP<sub>6.</sub> Arg 52 and Lys 49 are critical residues coordinating IP<sub>6</sub> binding in the peripheral site. Arg 28 and Asn 24 are critical residues coordinating IP<sub>6</sub> binding in the canonical site. Note that IP<sub>6</sub> does not bind to this mutant form of the PH-TH module. (<bold>E</bold>) Activation of full-length Btk, Btk R52S/K49S mutant, and Btk R28C/N24D mutant in the presence of IP<sub>6</sub> (100 μM).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.06074.019">http://dx.doi.org/10.7554/eLife.06074.019</ext-link></p></caption><graphic xlink:href="elife-06074-fig7-figsupp1-v2.tif"/></fig></fig-group></p><p>The four PH-TH modules in the asymmetric unit have six bound IP<sub>6</sub> molecules, each with clearly resolved electron density. Four of the IP<sub>6</sub> molecules are in the canonical binding sites on each module. At those sites, residues Asn 24, Tyr 39, Arg 28, and Lys 12 coordinate phosphate groups on the 2, 3, and 4 positions of the myo-inositol ring; these are also the key residues involved in IP<sub>4</sub> binding (<xref ref-type="bibr" rid="bib4">Baraldi et al., 1999</xref>) (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). The loop between strands β1 and β2, which is important for IP<sub>4</sub> binding, is largely disordered in our structure (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). There are fewer interactions at the canonical site between the PH-TH module and IP<sub>6</sub> than seen for IP<sub>4</sub>, consistent with the relative affinities of the two ligands (<xref ref-type="fig" rid="fig6">Figure 6A</xref>).</p><p>The two other IP<sub>6</sub> molecules in the crystallographic asymmetric unit are bound at a peripheral site. This site is on the surface formed by an elongated β hairpin involving strands β3 and β4 of each PH-TH module. This site has not been seen in any other PH domain (<xref ref-type="bibr" rid="bib40">Lemmon, 2008</xref>); it differs from the two well-characterized lipid-binding sites in the PH domains of Pleckstrin (<xref ref-type="bibr" rid="bib23">Ferguson et al., 1995</xref>) and β-spectrin (<xref ref-type="bibr" rid="bib29">Hyvönen et al., 1995</xref>). As in the canonical binding site, interactions between IP<sub>6</sub> and the peripheral site are predominantly electrostatistic (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). Unlike the canonical site, which has a well-defined groove within which the inositol phosphates are bound, the peripheral site is relatively flat (<xref ref-type="fig" rid="fig7">Figure 7B</xref>).</p><p>A feature of the crystallographic lattice is that IP<sub>6</sub> bound at the peripheral site is sandwiched between two PH-TH modules, interacting with the peripheral sites on both (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A,C</xref>). The majority of interactions are with one subunit. Residues Arg 49, Lys 52, Lys 36, and Tyr 40 at the peripheral binding site of one subunit (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1C</xref>) coordinate phosphate groups at the 1, 2, 3, and 4 positions of the myo-inositol ring. A subset of these residues, Lys 52 and Lys 36, on the other PH-TH module interact from the opposite side of the myo-inositol ring with the phosphate group at position 3 (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1C</xref>). The bridging interactions provided by IP<sub>6</sub> generate an open-ended chain of PH-TH dimers in the crystal lattice (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A</xref>). Based on the limited interactions across this crystallographic interface, we do not believe that this open-ended chain is relevant to the function of Btk.</p></sec><sec id="s2-10"><title>The peripheral binding site is critical for IP<sub>6</sub>-mediated Btk activation</title><p>We mutated Arg 49 and Lys 52, in the peripheral binding site of the PH-TH module, to serine in full-length Btk. This Btk variant autophosphorylates slowly, as does wild-type Btk, and it has very little response to IP<sub>6</sub> (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). In ITC experiments, we saw no detectable binding when we added IP<sub>6</sub> to a PH-TH module with mutations at both the canonical and the peripheral sites, further confirming that the residual binding of IP<sub>6</sub> to the IP<sub>4</sub>-binding deficient mutant is at the peripheral binding site (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1E</xref>).</p><p>The disposition of the IP<sub>6</sub> molecule can be determined unambiguously from the electron density because the phosphate group at the 2 position juts out from the plane of the myo-inositol ring (<xref ref-type="fig" rid="fig7">Figure 7E</xref>). IP<sub>6</sub> at the peripheral binding site interacts with the primary PH-TH module to which it is bound through the phosphates at positions 1, 2, 3, and 4. None of the inositol phosphates used in our experiments, other than IP<sub>6</sub>, can fully satisfy this criterion, which may underlie the specificity of the PH-TH module for IP<sub>6</sub>. Two isomers of IP<sub>5</sub>, I(2,3,4,5,6)P<sub>5</sub> and I(1,2,3,5,6)P<sub>5,</sub> have a mildly activating effect on Btk; they are more effective than I(1,3,4,5,6)P<sub>5</sub>. These comparisons indicate an important role in Btk activation for the phosphate at position 2 (<xref ref-type="fig" rid="fig5">Figure 5B</xref>).</p><p>In the cell, the only known enzyme that can add a phosphate to the hydroxyl group at position 2 of a myo-inositol ring is inositol 1,3,4,5,6-pentakisphosphate 2-kinase (<xref ref-type="bibr" rid="bib78">York et al., 1999</xref>), which produces IP<sub>6</sub>. As a consequence, IP<sub>6,</sub> and inositol pyrophosphates, such as IP<sub>7</sub> and IP<sub>8</sub>, may be the only cellular phosphates that can interact with the peripheral site in the Btk PH-TH module.</p></sec><sec id="s2-11"><title>A dimer of the PH-TH module is critical for IP<sub>6</sub>-mediated Btk activation</title><p>Strong activation of Btk by concentration on PIP<sub>3</sub>-containing membranes suggests that IP<sub>6</sub> might promote dimerization or oligomerization of Btk in solution. Neither multi-angle light scattering nor size exclusion chromatography gave convincing evidence for IP<sub>6</sub>-induced association, at Btk concentrations up to 30 μM. Nevertheless, we found it striking that in every crystal structure of the Btk PH-TH module, as well as in our structure of the PH-TH-kinase construct, the module forms very similar crystallographic dimers (<xref ref-type="fig" rid="fig7">Figure 7D</xref>) (PDB entry: 1BTK [<xref ref-type="bibr" rid="bib30">Hyvönen and Saraste, 1997</xref>]; PDB entry:1B55 and 1BWN [<xref ref-type="bibr" rid="bib4">Baraldi et al., 1999</xref>]; see also PDB entry: 2Z0P). This dimer was first identified and discussed by Marko Hyvönen and the late Matti Saraste; we refer to it as the ‘Saraste dimer’.</p><p>The Saraste dimer is formed by symmetric interactions between helix α1 and strands β3 and β4 of the PH-TH module (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). The largely hydrophobic dimer interface has a buried surface area of ∼1000 Å<sup>2</sup> on each molecule. Phe 44 and Tyr 42 on strand β3, Ile 9 on strand β1 and IIe 95 on helix α1 create a hydrophobic patch in one subunit of the dimer that packs tightly against the corresponding patch on the other subunit (<xref ref-type="fig" rid="fig8">Figure 8A</xref>).<fig id="fig8" position="float"><object-id pub-id-type="doi">10.7554/eLife.06074.020</object-id><label>Figure 8.</label><caption><title>The Saraste dimer of the PH-TH module is critical for Btk activation by IP<sub>6.</sub></title><p>(<bold>A</bold>) Molecular details of the Saraste dimer interface in the crystal structure of the IP<sub>6</sub>-bound PH-TH module. (<bold>B</bold>) End-point autophosphorylation assays for wild-type Btk, Btk L29R/I9R mutant, Btk I94R/I95R mutant, and Btk Y42R/F44R mutant in the presence and absence of IP<sub>6</sub> (100 μM). The measurements were made after incubating the proteins with and without IP<sub>6</sub> in the presence of ATP/Mg<sup>2+</sup> for 5 min. Residues Leu 29, Ile 9, IIe 94, IIe 95 Tyr 42 and Phe 44 are located in the Saraste dimer interface, as shown in panel <bold>A</bold>. Activation of the Btk Y42R/F44R mutant is shown in the lower panel. (<bold>C</bold>) Activation of the Btk-Abl fusion construct (1 μM) and that of a variant of this fusion protein in which the Btk PH-TH module is mutated (Y42R/F44R). Measurements were made with 1 μM protein in the presence and absence of IP<sub>6</sub> (100 μM).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.06074.020">http://dx.doi.org/10.7554/eLife.06074.020</ext-link></p></caption><graphic xlink:href="elife-06074-fig8-v2.tif"/></fig></p><p>To test whether the Saraste dimer interface is important for IP<sub>6</sub>-mediated Btk activation, we made three mutants in which we replaced hydrophobic residues at the Saraste dimer interface with arginines and compared their autophosphorylation rates and their response to IP<sub>6</sub> with those of wild-type Btk. All three sets of mutant proteins showed little or no response to IP<sub>6</sub> (<xref ref-type="fig" rid="fig8">Figure 8B</xref>). These mutations do not affect the autophosphorylation rate of Btk in the absence of IP<sub>6</sub>. We conclude that the Saraste dimer interface promotes Btk association in the presence of IP<sub>6</sub>.</p><p>The activation of Class I Histone Deacetylases (HDACs) requires the formation of a multi-subunit co-repressor complex, in which Ins(1,4,5,6)P<sub>4</sub> serves as an intermolecular glue that cements the complex together (<xref ref-type="bibr" rid="bib72">Watson et al., 2012</xref>; <xref ref-type="bibr" rid="bib46">Millard et al., 2013</xref>). The mechanism of IP<sub>6</sub>-induced transient Btk dimerization is fundamentally different, in that the peripheral IP<sub>6</sub> binding site is just outside the Saraste dimer interface, and IP<sub>6</sub> does not participate in any interactions between the two Btk subunits in that dimer.</p></sec><sec id="s2-12"><title>Fusing the Btk PH-TH module to the catalytic module of c-Abl promotes autophosphorylation of c-Abl in the presence of IP<sub>6</sub></title><p>If the effect of IP<sub>6</sub> arises from its ability to promote dimerization of the PH-TH module, fusion of a Btk PH-TH module with the catalytic domain of another kinase that autophosphorylates slowly should impart activation by IP<sub>6</sub>. A good example of such a kinase is c-Abl. Indeed, in chronic myelogenous leukemia, a chromosomal translocation results in fusion of a coiled-coil oligomerization domain with c-Abl, leading to hyper-activation of the BCR-Abl fusion protein by autophosphorylation. Several other fusion variants involving c-Abl, in which different oligomerization domains are present, are associated with hematological malignancies (<xref ref-type="bibr" rid="bib17">De Braekeleer et al., 2011</xref>).</p><p>We generated a PH-TH-Abl fusion construct in which the PH-TH module of Btk is fused to the SH2-kinase module of c-Abl. We compared autophosphorylation rates of the PH-TH-Abl fusion protein with and without IP<sub>6</sub> at a saturating concentration (100 μM). The fusion protein at a concentration of 1 μM autophosphorylated slowly in the absence of IP<sub>6</sub>, while the IP<sub>6</sub>-bound protein became heavily phosphorylated within the first 30 s, the dead-time of our assay (<xref ref-type="fig" rid="fig8">Figure 8C</xref>). We replaced Phe 44 and Tyr 42, at the Saraste dimer interface, with arginine in the fusion protein. The autophosphorylation rate of the PH-TH-Abl mutant in the presence of IP<sub>6</sub> was much lower than that of the IP<sub>6</sub>-bound wild-type protein, further evidence for the importance of the Saraste dimer interface in IP<sub>6</sub>-mediated activation (<xref ref-type="fig" rid="fig8">Figure 8C</xref>).</p><p>The Btk and c-Abl kinase domains are 46% identical in sequence, but most of the surface residues are different. We infer that, except for its enzymatic activity, the interaction properties of the Btk kinase domain are not important for the IP<sub>6</sub> response. Because IP<sub>6</sub> activates both kinases when they are linked to the Btk PH-TH module, we propose that IP<sub>6</sub> promotes transphosphorylation of the attached kinase by inducing transient dimerization.</p><p>Our preliminary studies indicate that the IP<sub>6</sub>-induced dimerization of the Btk PH-TH module is very weak, with a dissociation constant that is likely to be greater than 100 μM. It might appear counter-intuitive that IP<sub>6</sub> can markedly accelerate activation at 2 μM Btk concentration, well below the dissociation constant. A simple calculation shows that even a modest increase in a small dimer population can lead to a sharp change in the rate of activation because the reaction is autocatalytic. The initial production of phosphorylated Btk drives the further production of this species at an accelerating rate (<xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1B</xref>).</p></sec><sec id="s2-13"><title>Speculations about the mechanism of IP<sub>6</sub> activation</title><p>Our failure to detect stable dimers of the Btk PH-TH module or of full-length Btk in the presence of IP<sub>6</sub> suggests that the monomeric PH-TH module has a conformation different from the one seen in crystal structures, which all show the same dimer contact. The high protein concentration in the crystal lattice (∼30 mM) presumably drives the formation of the Saraste dimer, which is otherwise not favored.</p><p>Molecular dynamics simulations suggest that the conformation of the PH-TH module seen in the Saraste dimer is unstable when the protein is monomeric. We initiated molecular dynamics trajectories using a monomeric PH-TH module from a crystal structure which contained neither IP<sub>6</sub> nor IP<sub>4</sub>. Within the first 30 ns of simulation, the β3-β4 hairpin bent towards the core of the PH-TH module (<xref ref-type="fig" rid="fig9">Figure 9A</xref> and <xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1A</xref>), and Phe 44, at the heart of the Saraste dimer interface, changed its conformation and packed against the other three interfacial residues, Tyr 42, Ile 9, and IIe 95 (<xref ref-type="fig" rid="fig9">Figure 9A</xref>). This conformational change closed the dimer interface, burying the interfacial residues.<fig-group><fig id="fig9" position="float"><object-id pub-id-type="doi">10.7554/eLife.06074.021</object-id><label>Figure 9.</label><caption><title>Possible allosteric and electrostatic effects of binding IP<sub>6</sub>.</title><p>(<bold>A</bold>) Fluctuations of the PH-TH module during a molecular dynamic simulation. An instantaneous structure (t = 100 ns) from a 100 ns simulation of the PH-TH module shows a conformational change that closes the Saraste dimer interface (middle panel). Replacing these hydrophobic residues (IIe 9, Tyr 42, Phe 44 and Ile 95) with alanine prevents the dimer interface from closing in the simulations (lower panel). Although the β3/β4 loop becomes more dynamic, it remains open (see <xref ref-type="fig" rid="fig9s1">Figure 9–figure supplement 1</xref>). Binding of IP<sub>6</sub> may shift the equilibrium between open and closed conformations. (<bold>B</bold>) Activation of the Btk R52E/K49E mutant (2 μM). Arg 52 and Lys 49 are two residues in the peripheral binding site. Mutation of these two residues to glutamate reduces the local charge at the peripheral site by a net four units, and results in Btk activation.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.06074.021">http://dx.doi.org/10.7554/eLife.06074.021</ext-link></p></caption><graphic xlink:href="elife-06074-fig9-v2.tif"/></fig><fig id="fig9s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.06074.022</object-id><label>Figure 9—figure supplement 1.</label><caption><title>Flexibility in the PH domain of Btk and simulation of the kinetics of Btk autophosphorylation.</title><p>(<bold>A</bold>) Fluctuations in the β3/β4 loop of the wild-type PH-TH module and its I9A/Y42A/F44A/I95A variant. Each trajectory was sampled every 1 ns. The instantaneous structures are aligned using the crystal structure as the reference. The r.m.s. deviation was calculated for the backbone of residues 36 through 57 of the PH-TH domain. (<bold>B</bold>) Simulations of the kinetics of Btk autophosphorylation. We consider a very simple two-step Michaelis–Menten model for autophosphorylation, in which two Btk molecules first form an encounter complex, followed by phosphorylation of one of the two molecules in the complex. We assume that the rate of complex formation increases if IP<sub>6</sub> is bound, and that the catalytic rate constant for phosphorylation of the other increases if one of the two Btk molecules is phosphorylated. This model is described by the following reaction scheme:<disp-formula id="equ6"><label>(1)</label><mml:math id="m6"><mml:mrow><mml:mtext>Btk</mml:mtext><mml:mo>+</mml:mo><mml:mtext>Btk</mml:mtext><mml:munderover><mml:mo>⇌</mml:mo><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:munderover><mml:mtext>Btk</mml:mtext><mml:mo>·</mml:mo><mml:mtext>Btk</mml:mtext><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula><disp-formula id="equ7"><label>(2)</label><mml:math id="m7"><mml:mrow><mml:mtext>Btk</mml:mtext><mml:mo>·</mml:mo><mml:mtext>Btk</mml:mtext><mml:mrow><mml:mover accent="true"><mml:mo>→</mml:mo><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mover></mml:mrow><mml:mtext>pBtk</mml:mtext><mml:mo>+</mml:mo><mml:mtext>Btk</mml:mtext><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula><disp-formula id="equ8"><label>(3)</label><mml:math id="m8"><mml:mrow><mml:mtext>pBtk</mml:mtext><mml:mo>+</mml:mo><mml:mtext>Btk</mml:mtext><mml:munderover><mml:mo>⇌</mml:mo><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:munderover><mml:mtext>pBtk</mml:mtext><mml:mo>·</mml:mo><mml:mtext>pBtk</mml:mtext><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula><disp-formula id="equ9"><label>(4)</label><mml:math id="m9"><mml:mrow><mml:mtext>pBtk</mml:mtext><mml:mo>·</mml:mo><mml:mtext>Btk</mml:mtext><mml:mrow><mml:mover accent="true"><mml:mo>→</mml:mo><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:mover></mml:mrow><mml:mtext>pBtk</mml:mtext><mml:mo>+</mml:mo><mml:mtext>pBtk</mml:mtext><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula>The on-rate for a diffusion-limited encounter between two proteins is in the range of 10<sup>8</sup> to 10<sup>7</sup> M<sup>−1</sup>s<sup>−1</sup>. We assume that in the absence of IP<sub>6</sub> the on-rate for Btk dimer formation is much slower than this (<italic>k</italic><sub>1</sub> = <italic>k</italic><sub>3</sub> = 10<sup>4</sup> M<sup>−1</sup>s<sup>−1</sup>) and that IP<sub>6</sub> binding increases the on-rate by 10-fold (<italic>k</italic><sub>1</sub> = <italic>k</italic><sub>3</sub> = 10<sup>5</sup> M<sup>−1</sup>s<sup>−1</sup>). The dissociation rate constant is chosen so that the dissociation constant is 2 mM and 200 μM in the absence and presence of IP<sub>6</sub>, respective (<italic>k</italic><sub>-1</sub> = <italic>k</italic><sub>-3</sub> = 20 s<sup>−1</sup>). The catalytic constant (<italic>k</italic><sub>4</sub>) for activated Btk is set to 1.0 s<sup>−1</sup>, comparable to the values determined for other tyrosine kinases, such as Src and ZAP70 (<xref ref-type="bibr" rid="bib50">Mukherjee et al., 2013</xref>). We assume that the catalytic constant is 10-fold smaller for unphosphorylated Btk (<italic>k</italic><sub>2</sub> = 0.1 s<sup>−1</sup>). To compare with our experimental data, the initial concentration of Btk was set at 1 μM. The integration of the differential kinetic equations was done using BerkeleyMadonna (<ext-link ext-link-type="uri" xlink:href="http://www.berkeleymadonna.com/">http://www.berkeleymadonna.com/</ext-link>). As shown in the diagram, the autophosphorylation kinetics generated by this simple reaction scheme is consistent with the experimentally observed kinetics.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.06074.022">http://dx.doi.org/10.7554/eLife.06074.022</ext-link></p></caption><graphic xlink:href="elife-06074-fig9-figsupp1-v2.tif"/></fig></fig-group></p><p>The hydrophobicity of the dimer interface drove the observed conformational change. Molecular dynamics simulations initiated from crystal structures but with the four interfacial residues substituted by alanine reduced the extent of conformational change in this area (<xref ref-type="fig" rid="fig9">Figure 9A</xref>). The peripheral binding site for IP<sub>6</sub> is adjacent to the β3-β4 hairpin that folds in and closes the dimer interface in the simulation. Thus, one effect of IP<sub>6</sub> binding may be to stabilize the open form of the hairpin.</p><p>It also appears that IP<sub>6</sub> might act by altering the electrostatic potential of the PH-TH module. We examined the surface electrostatic potential of the Btk PH-TH module by viewing graphical displays of solutions to the Poisson-Boltzmann equation (<xref ref-type="bibr" rid="bib20">Dolinsky et al., 2004</xref>, <xref ref-type="bibr" rid="bib19">2007</xref>). The PH-TH domain carries seven net positive charges; it is also electrostatically polarized, with the positively charged residues concentrated on the broad, contiguous surface composed of the β3-β4 hairpin, the IP<sub>4</sub> binding loop and the N-terminal region of the loop connecting strand β5 and helix α2. In the Saraste dimer, positive electrostatic field lines calculated based on the monomer run into each other at the dimer interface, suggesting that electrostatic forces oppose dimer formation.</p><p>We introduced two charge-reversal mutations at the peripheral IP<sub>6</sub>-binding site (K49E and R52E), to reduce the positive charge on the protein by four units. The autophosphorylation rate of full-length Btk with the K49E/R52E mutations was substantially higher than that of the wild-type protein, with pronounced phosphorylation observed in the first 2 min of the reaction (<xref ref-type="fig" rid="fig9">Figure 9B</xref>).</p><p>We suggest that there are two barriers to the dimerization of the PH-TH module of Btk. First, the dimer interface of the PH domain is probably closed in the monomeric protein. Second, an electrostatic repulsion between PH domains further impedes dimerization. IP<sub>6</sub> binding might stabilize the open form of the PH-TH module allosterically, while also alleviating the electrostatic repulsion.</p></sec><sec id="s2-14"><title>Conclusions</title><p>Our studies on Btk have revealed the structural basis for its autoinhibition. One key finding is that the Src-like module of Btk adopts a compact and autoinhibited form that resembles the autoinhibited structures of the Src kinases and c-Abl, in which the SH3 domain binds to the SH2-kinase linker and holds the kinase domain in an inactive conformation. Our structure of the PH-TH-kinase construct of Btk shows that the PH-TH module stablizes the inactive conformation of the kinase domain, as well as the assembled conformation of the Src-like module of Btk.</p><p>A second, and quite unexpected, finding is that IP<sub>6</sub> can activate Btk strongly by binding to a newly identified site on the PH domain, probably by promoting transient dimerization of the PH-TH module. Because IP<sub>6</sub> synthesis requires the precursor molecule IP<sub>3</sub>, which is itself produced as a result of Btk activation, a transient elevation of IP<sub>6</sub> may create a positive feedback loop for Btk activation, either on the membrane or in the cytoplasm. Formation of the Saraste dimer interface is compatible with the simultaneous engagement of PIP<sub>3</sub> by both PH domains in the dimer, raising the possibility that IP<sub>6</sub> can stimulate dimerization of membrane-tethered Btk (<xref ref-type="fig" rid="fig10">Figure 10</xref>). IP<sub>6</sub> binding to the peripheral binding site may also enhance PIP<sub>3</sub> affinity in the canonical binding site and sensitize Btk to PIP<sub>3</sub> levels. The linker connecting the PH-TH unit to the SH3 domain promotes dimerization of Btk by interacting with the SH3 domain of a second molecule, providing an additional mechanism for Btk dimerization at high local concentration (<xref ref-type="bibr" rid="bib37">Laederach et al., 2002</xref>). High levels of IP<sub>6</sub> may down-regulate the amount of Btk on membranes by competing for PIP<sub>3</sub> binding in the canonical binding site, as proposed for Akt1 regulation by IP<sub>7</sub> (<xref ref-type="bibr" rid="bib13">Chakraborty et al., 2010</xref>).<fig-group><fig id="fig10" position="float"><object-id pub-id-type="doi">10.7554/eLife.06074.023</object-id><label>Figure 10.</label><caption><title>Models of Btk autoinhibition and activation.</title><p>(<bold>A</bold>) The PH-TH module stabilizes the assembled conformation of the Src-like module of Btk in its inactive conformation. The activation of Btk involves formation of a transient dimer through the PH-TH module, which promotes trans-autophosphorylation and activates Btk. The stimulation of dimerization could occur at the membrane or in solution, as in our experiments. (<bold>B</bold>) IP<sub>6</sub> may stimulate membrane-tethered Btk. Formation of the Saraste dimer is compatible with the simultaneous engagement of PIP<sub>3</sub> by both PH domains in the dimer, and is compatible with the binding of IP<sub>6</sub> at the peripheral binding site. This raises the possibility that IP<sub>6</sub> can stimulate dimerization of the membrane-tethered Btk.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.06074.023">http://dx.doi.org/10.7554/eLife.06074.023</ext-link></p></caption><graphic xlink:href="elife-06074-fig10-v2.tif"/></fig><fig id="fig10s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.06074.024</object-id><label>Figure 10—figure supplement 1.</label><caption><title>Sequence alignment of Btk and Itk.</title><p>The alignment was performed using ClustalW2 (<xref ref-type="bibr" rid="bib38">Larkin et al., 2007</xref>) and visualized by Espript3 (<xref ref-type="bibr" rid="bib58">Robert and Gouet, 2014</xref>). The alignment shows that the adoption of the compact autoinhibited conformation by the Src-like module, seen in our crystal structures, is likely to be conserved in Itk. In contrast, residues at the Saraste dimer interface and at the peripheral IP<sub>6</sub> binding site in Btk are not conserved in Itk.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.06074.024">http://dx.doi.org/10.7554/eLife.06074.024</ext-link></p></caption><graphic xlink:href="elife-06074-fig10-figsupp1-v2.tif"/></fig></fig-group></p><p>The Src-like modules of Btk and Itk have 55% sequence identity, with all the residues critical for maintaining the assembled and autoinhibited Src-like conformation of Btk conserved in Itk (<xref ref-type="fig" rid="fig10s1">Figure 10—figure supplement 1</xref>). The Src-like module of Itk is therefore likely also to adopt the assembled Src-like conformation when inactive.</p><p>The roles of the PH-TH module in regulating Btk activity are not likely to be conserved in Itk. The four residues at the peripheral binding site that coordinate IP<sub>6</sub> in Btk are not conserved in Itk, unlike those that coordinate PIP<sub>3</sub>/IP<sub>4</sub> at the canonical lipid-binding site. This lack of conservation also extends to the key residues at the inhibitory interface between the PH-TH module and the kinase domain in Btk and to residues at the Saraste dimer interface (<xref ref-type="fig" rid="fig10s1">Figure 10—figure supplement 1</xref>). A different soluble inositol phosphate, IP<sub>4</sub>, promotes PIP<sub>3</sub> binding by the Itk PH-TH module; this activity is important for Itk regulation in T-cells (<xref ref-type="bibr" rid="bib27">Huang et al., 2007</xref>). Thus, regulation by soluble inositol phosphates may be a general feature of Tec family kinases, but the specific effector and the molecular mechanism of the kinase response may be different in each case. The regulation of tyrosine kinases by soluble second messengers has not received much attention in the past. Our discovery that IP<sub>6</sub> activates Btk, along with the known effect of IP<sub>4</sub> on Itk, points to the importance of further studies on these and soluble effectors.</p></sec></sec><sec id="s3" sec-type="materials|methods"><title>Materials and methods</title><sec id="s3-1"><title>Protein expression and purification</title><sec id="s3-1-1"><title>Insect cell expression, purification, and characterization of mouse Btk</title><p>DNA for mouse Btk (residues 214 to 659; the Src-like module) was used to prepare baculovirus. Infected Sf21 cells were harvested by centrifugation 72 hr post-infection, then frozen in liquid nitrogen for storage. Cells were later thawed, resuspended in 25 mM Tris·Cl, pH 8.0, 50 mM NaCl, 5 mM DTT, 5 mM benzamidine, and complete protease inhibitor tablets (Roche Diagnostics, Switzerland), and lysed mechanically by Dounce homogenization followed by brief sonication. All remaining steps were carried out at 4°C. Cellular debris was cleared by centrifugation at 96,000×<italic>g</italic> for 1 hr, after which the supernatant was passed through a 0.45-μm filter. Cleared supernatant was loaded on to DEAE sepharose pre-equilibrated with 25 mM Tris·Cl, pH 8.0, 25 mM NaCl, and 5 mM DTT. Protein was eluted by a linear gradient to 25 mM Tris·Cl, pH 8.0, 0.35 M NaCl, 5 mM DTT over 3.7 column volumes, with the Src-like module of Btk eluting at approximately 2.6 column volumes.</p><p>Fractions containing the Src-like module of Btk were identified by Western blot, pooled, brought to 0.7 M ammonium sulfate, then loaded on to a phenyl sepharose column pre-equilibrated with 50 mM Tris·Cl, pH 8.0, 0.7 M ammonium sulfate, and 5 mM DTT. Contaminating protein was removed by an initial step to 0.2 M ammonium sulfate and the column eluted with a linear gradient to 50 mM Tris·Cl, pH 8.0 and 5 mM DTT over four column volumes. The Src-like module of Btk eluted as a broad peak starting at approximately 0.18 M ammonium sulfate.</p><p>Fractions containing significant amounts of the Src-like module of Btk, identified by SDS PAGE, were pooled and concentrated using Centricon Plus-80 concentrators (Millipore, Billerica MA). Concentrated protein was dialyzed against 4 × 1 liter changes of 25 mM Tris·Cl, pH 8.5, 25 mM NaCl, 5 mM DTT. That buffer, excepting changes to the NaCl concentration, was maintained through the rest of the purification. After dialysis, protein was loaded on to a mono-Q HR 10/10 column, and eluted with a linear gradient from 50 mM NaCl to 250 mM NaCl over twenty column volumes, with the protein eluting as two peaks at approximately 100 mM NaCl (peak A) and 150 mM NaCl (peak B), respectively. Fractions from the two peaks were pooled separately. Fractions from peak B were dialyzed against buffer containing 20 mM NaCl. The two pools could then be concentrated using Centricon-10 concentrators (Millipore). They were loaded separately onto a HiPrep S-200 16/60 size exclusion column pre-equilibrated in buffer containing 25 mM NaCl. Peak A eluted at the position corresponding to a globular protein of molecular mass 55 kDa, the value expected for a monomer of the Src-like module. Peak B eluted at a position corresponding of 140 kDa, compatible with an extended dimer. The protein in peak A could be concentrated using Centricon concentrators to approximately 20 mg/ml, while peak B required dialysis against a buffer containing no more than 10 mM NaCl, followed by concentration in dialysis tubing laid on PEG 20,000 at 4°C. In this way, the dimeric protein could be concentrated to approximately 10 mg/ml.</p><p>Peaks A and B were definitively identified as the Src-like module of Btk monomer and dimer, respectively, by chemical cross-linking using disuccinimidyl glutarate (Pierce Biotechnology, Waltham MA) and PAGE analysis (results not shown). All column media and pre-packed columns were purchased from Amersham Biosciences.</p></sec></sec><sec id="s3-2"><title>Bacterial expression and purification of full-length bovine Btk and the PH-TH-kinase construct</title><p>DNA encoding bovine Btk (residues 1 to 659) was cloned into pET-28 expression plasmid yielding N-terminally 6-histidine-tagged SUMO-fusion protein. The hexahistidine-SUMO tag was cleavable by Ulp-1 SUMO-specific protease. For protein expression, the plasmid was transformed into BL21 DE3* (Novagen, Australia) cells that also contain the expression plasmids for GroES/GroEL and phosphatase YopH (<xref ref-type="bibr" rid="bib60">Seeliger et al., 2005</xref>), and then grown in Terrific Broth (TB) media supplemented with 50 mg/l kanamycin, 50 mg/l streptomycin, and 50 mg/l chloramphenicol at 37°C. At a cell density corresponding to an absorbance of 1.5 at 600 nm, the temperature was reduced to 18°C, and protein production was induced by mixing the bacterial culture with equal volume of 4°C TB media supplemented with 1 mM IPTG, 100 μM ZnCl<sub>2</sub>, 50 mg/l Kanamycin, 50 mg/l streptomycin, and 50 mg/l chloramphenicol. After 16 hr, cells were harvested by centrifugation, resuspended in Ni-NTA buffer A (500 mM NaCl, 20 mM imidazole, 25 mM Tris pH 8.5, 5% glycerol, and 1 mM DTT), and flash-frozen in liquid nitrogen. Cells were then thawed on ice and supplemented with a mixture of protease inhibitors (aprotinin 2 μg/ml, benzamidine 15 μg/ml, leupeptin 2 μg/ml, PMSF 1 mM, pepstatin A, 1 μg/ml).</p><p>After cell lysis by French press and removal of cell debris by centrifugation, clear lysates were loaded onto a HisTrap Ni-NTA column (GE Healthcare, UK), washed with 100 ml Ni-NTA buffer A. Proteins were eluted with a single step of Ni-NTA buffer A supplemented with 250 mM imidazole. Proteins were buffer exchanged into storage buffer (25 mM Tris-HCl, pH 8.0, 400 mM NaCl) by FastFlow desalting column (GE Healthcare), and affinity tags were removed by incubation with Ulp-1 protease at 4°C overnight. Cleaved proteins were collected in the flow-through during Ni-NTA affinity chromatography and were subjected to size-exclusion chromatography on a Superdex 200 column (GE Healthcare) equilibrated in storage buffer. Proteins were concentrated on an AmiconUltra centrifugal filter device (50 kDa cutoff; Millipore) to a final concentration of ∼400 μM. Protein aliquots were frozen in liquid nitrogen and stored at −80°C.</p><p>The Src-like module (residues 217 to 659), SH2-kinase module (residues 270 to 659), and the kinase domain (residues 394 to 659) of bovine Btk, various bovine Btk PH-TH-kinase constructs and the PH-TH-Abl fusion construct (BTK residues 1 to 216 fused to human c-Abl residues 140 to 518) were all expressed and purified using the same protocol. The PH-TH module of bovine Btk (residues 1 to 172) was prepared in the same way as described above expect that the co-expression of GroEL/GroES and YopH is not necessary.</p></sec><sec id="s3-3"><title>Crystallization and structure determination</title><sec id="s3-3-1"><title>The Src-like module of mouse Btk</title><p>The crystals of the dimeric protein (peak B) were grown using hanging-drop vapor diffusion at 4°C by mixing purified protein at 5 mg/ml in 25 mM Tris·Cl, pH 8.5, 10 mM NaCl, 5 mM DTT with an equal volume of the precipitant solution, 100 mM Tris·Cl, pH 8.5, 200 mM Na·acetate, 7.5% PEG 4000. Wedge-shaped crystals grew to approximately 0.1 mm on a side after a period of 2 weeks. These crystals could be frozen by first transferring them, in four sequential steps, to a solution of 100 mM Tris·Cl, pH 8.5, 200 mM Na·acetate, 15% PEG 4000, followed by transfer in six sequential steps to a solution containing 100 mM Tris·Cl, pH 8.5, 200 mM Na·acetate, 15% PEG 4000, 30% glucose. The monomeric protein (peak A) did not yield crystals.</p><p>Data were collected at the Cornell High Energy Synchrotron Source (CHESS), beamline A1. Anomalous data, when present, were collected by the inverse beam method. Four sets of data contributed to the structure determination, collected from crystals in 5 mM KAu(CN)<sub>2</sub>, 1 mM dimercuriacetate (DMA), 3 mM Au(NO<sub>3</sub>)<sub>4</sub>, and no adduct, respectively (<xref ref-type="table" rid="tbl2">Table 2</xref>). A heavy-atom partial structure was solved by inspection of KAu(CN)<sub>2</sub> anomalous difference Patterson maps, which revealed two heavy binding sites. Heavy-atom positions were then refined using SHARP (<xref ref-type="bibr" rid="bib8">Bricogne et al., 2003</xref>), and difference electron density maps were used to locate a single heavy-atom position in the DMA derivative. Individual mercury atoms within the DMA molecule could not be resolved due to high B-values, so the heavy-atom compound was modeled as a point scatterer. Other derivatives were not useful for MIR phasing, due either to a lack of isomorphism or the presence of overlapping heavy-atom sites. Density modification was performed after heavy-atom refinement in SHARP using the default solvent flipping protocol (<xref ref-type="bibr" rid="bib8">Bricogne et al., 2003</xref>).</p><p>The kinase domain was built into the density modified maps with reference to the already determined Btk kinase domain structure (PDB ID 1K2P), after separately placing the large and small lobes. The SH3 domain was built by comparison with the c-Src SH3 domain (PDB ID 2SRC).</p><p>We generated a homology model for the SH2 domain from the SH2 domains present in PDB entries for Src, Hck and Abl containing SH3-SH2-kinase constructs (PDB IDs: 1FMK, 1KSW, 2SRC, 2PTK, 1AD5, 1QCF, 2HCK, 1OPK). This model was placed by hand, aligning helices αA and αB into the unambiguous density, then refined as a rigid-body using a 4.0 Å resolution cutoff. Multiple crystal averaging across four distinct data sets (KAu(CN)<sub>2</sub>, DMA, Au(NO<sub>3</sub>)<sub>4</sub> and native, using the program DMMULTI (<xref ref-type="bibr" rid="bib15">Cowtan and Main, 1993</xref>; <xref ref-type="bibr" rid="bib74">Winn et al., 2011</xref>), revealed the domain swap in the secondary β-sheet portion of the SH2 domain.</p><p>The structure was refined using alternating cycles of manual rebuilding in the program O (<xref ref-type="bibr" rid="bib33">Jones et al., 1991</xref>) and torsional simulated annealing and grouped B-factor refinement against data to 2.8 Å using the program CNS_SOLVE (<xref ref-type="bibr" rid="bib10">Brunger et al., 1998</xref>; <xref ref-type="bibr" rid="bib9">Brunger, 2007</xref>). A final refinement of the model was performed using PHENIX (<xref ref-type="bibr" rid="bib1">Adams et al., 2002</xref>) to incorporate TLS as three groups, defined as residues 214–260, 261–391, and 392–657. These groups were identified by the automated TLS group search procedure and agreed well with the character of the experimental maps. In all refinement runs in which the SH2 domain was present, an initial temperature factor was refined for the entire SH2 domain, and then the SH2 domain was fixed. SH2 domain geometry is thus strictly a result of the geometry of the initial homology model. Data collection and refinement statistics are summarized in <xref ref-type="table" rid="tbl2">Table 2</xref>. Illustrations were made in Pymol (DeLano Scientific, New York NY).</p></sec><sec id="s3-3-2"><title>Structure of the PH-TH-kinase construct of bovine Btk</title><p>The bovine PH-TH-kinase construct (residues 1 to 170 connected to residues 384 to 659) was thawed on ice and mixed with twofold excess IP<sub>3</sub> (Avanti lipid) and inhibitor CGI1746 (Selleck Inc, Houston TX), and was incubated at 4°C for 30 min before setting up trays. IP<sub>3</sub> binds to the protein, but does not activate it. Although present in the crystallization mix, it is not visible in the final electron density (see below). Needle clusters of crystals were obtained by sitting drop vapor diffusion by mixing equal volume of protein solutions at 15 mg/ml with reservoir solution containing 200 mM NaCl, 50 mM MgCl<sub>2</sub>, and 20% PEG3350. To prepare seeds for microseeding, needle clusters were harvested and combined from 20 drops and transferred into a 1.5-ml eppendorf tube.</p><p>The bovine PH-TH-kinase construct with activation loop mutations (<xref ref-type="bibr" rid="bib34">Joseph et al., 2013</xref>) was prepared in the same way as was the wild-type protein. Equal volumes of protein solution and the reservoir solution containing 200 mM NaCl, 50 mM MgCl<sub>2</sub>, and 20% PEG3350 were mixed and were equilibrated in a hanging drop tray for 24 hr at 4°C. Microseeding was then performed by striping the wild-type crystal seeds using a cat whisker into the equilibrated drops. Large rock-like crystal clusters appeared ∼4 days after micro-seeding, and single crystals (typical dimensions of 0.20 mm × 0.15 mm × 0.25 mm) can be isolated. For cryo-protection, crystals were soaked in reservoir solution supplemented with 25% glycerol, and flash-frozen in liquid nitrogen and stored at 100 K.</p><p>Data were collected at the Lawrence Berkeley National Laboratory, Advanced Light Source (ALS), beamline 8.2.1. Data reduction was carried out with the software package HKL2000 (<xref ref-type="bibr" rid="bib52a">Otwinowski and Minor, 1997</xref>). The structure was determined by molecular replacement using PHENIX (<xref ref-type="bibr" rid="bib1">Adams et al., 2002</xref>) with two search models. These were the structure of the Btk kinase domain that has mutations in the activation loop (see below) and the structure of the PH-TH module. Refinement in PHENIX and COOT (<xref ref-type="bibr" rid="bib21">Emsley and Cowtan, 2004</xref>) yielded the final models. No density for IP<sub>3</sub> is seen in difference electron density maps, even at low contour levels (2σ above the mean in σ weighted |F<sub>o</sub>| − |F<sub>c</sub>| difference maps). Data collection and refinement statistics are summarized in <xref ref-type="table" rid="tbl1">Table 1</xref>. Illustrations were made in Pymol (DeLano Scientific).</p></sec><sec id="s3-3-3"><title>Structure of the Btk PH-TH module bound to IP<sub>6</sub></title><p>The bovine Btk PH-TH module (residues 1 to 172) sample was thawed at room temperature and was incubated with fivefold excess IP<sub>6</sub> (Sigma) for 10 min. Plate-like crystals were obtained by sitting drop vapor diffusion by mixing equal volume of protein sample solution and the reservoir solution containing 25% PEG1500 and 0.1 M DL-malic acid pH 5.5. Crystals were then transferred to cryo-protection solution, which is the reservoir solution supplemented with 30% glycerol and 3 mM IP<sub>6</sub>.</p><p>Data were collected at the Lawrence Berkeley National Laboratory, Advanced Light Source (ALS), beamline 8.2.1. Data reduction was carried out with the software package HKL2000 (<xref ref-type="bibr" rid="bib52a">Otwinowski and Minor, 1997</xref>). The structure was determined by molecular replacement using PHENIX (<xref ref-type="bibr" rid="bib1">Adams et al., 2002</xref>) with the structure of the PH-TH module as the search model (PDB: 1BTK) (<xref ref-type="bibr" rid="bib30">Hyvönen and Saraste, 1997</xref>). Refinement in PHENIX and COOT (<xref ref-type="bibr" rid="bib21">Emsley and Cowtan, 2004</xref>) yielded the final models. The structural restraint file for IP<sub>6</sub> was generated using REEL in PHENIX (<xref ref-type="bibr" rid="bib1">Adams et al., 2002</xref>) based on the conformation of IP<sub>6</sub> seen in the structure of Auxin receptor TIR1 (PDB: 2P1P) (<xref ref-type="bibr" rid="bib65">Tan et al., 2007</xref>). Data collection and refinement statistics are summarized in <xref ref-type="table" rid="tbl1">Table 1</xref>. Illustrations were made in Pymol (DeLano Scientific).</p></sec><sec id="s3-3-4"><title>Structure of the Btk kinase domain activation loop mutant</title><p>Btk kinase domain (residues 395 to 659) with the activation loop mutations (L542M, S543T, V555T, R562K, S564A, and P565S) (<xref ref-type="bibr" rid="bib34">Joseph et al., 2013</xref>) was thawed at room temperature and was incubated with twofold excess CGI1746 (Selleck Inc) and fivefold excess IP<sub>6</sub> (Sigma) for 10 min. Crystals were obtained by sitting drop evaporation methods by mixing equal volume of protein sample solution and the reservoir solution containing 0.2 M ammonium citrate dibasic and 20% PEG 3350. Crystals were then transferred to cryo-protection solution which is the reservoir solution supplemented with 30% glycerol and 3 mM IP<sub>6</sub>.</p><p>Data were collected at the Lawrence Berkeley National Laboratory, Advanced Light Source (ALS), beamline 8.2.1. Data reduction was carried out with the software package HKL2000 (<xref ref-type="bibr" rid="bib52a">Otwinowski and Minor, 1997</xref>). The structure was determined by molecular replacement using PHENIX (<xref ref-type="bibr" rid="bib1">Adams et al., 2002</xref>) with the structure of wild-type Btk kinase domain (PDB: 3OCS) (<xref ref-type="bibr" rid="bib18">Di Paolo et al., 2011</xref>). Refinement in PHENIX and COOT (<xref ref-type="bibr" rid="bib21">Emsley and Cowtan, 2004</xref>) yielded the final models. No density can be located for IP<sub>6</sub> in crystals. Data collection and refinement statistics are summarized in <xref ref-type="table" rid="tbl1">Table 1</xref>.</p></sec></sec><sec id="s3-4"><title>Preparation of autophosphorylated Btk</title><p>Btk samples were diluted to 4 μM using the buffer that contains 150 mM NaCl, 25 mM Tris, pH 7.5, and 5% glycerol. For experiments involving lipid vesicles and inositol phosphates, additional 500 μM lipid and 200 μM inositol phosphates are supplemented into the dilution buffer, respectively, followed by a 10-min incubation at room temperature.</p><p>The diluted samples were mixed with equal volume of the reaction buffer that contains 150 mM NaCl, 20 mM MgCl<sub>2</sub>, 2 mM ATP, 25 mM Tris, pH 7.5, 2 mM sodium vandate, and 5% glycerol and incubated at room temperature. The final concentration of Btk samples is 2 μM. At each time point, the samples were either frozen in liquid nitrogen and stored at −80°C for the coupled kinase assays, or mixed with equal volume of quench buffer that contains 2X SDS-PAGE buffer supplemented with 100 mM EGTA, followed by incubating at 95°C in a heat block for 15 min for western blot assays.</p></sec><sec id="s3-5"><title>Coupled kinase assay</title><p>A continuous pyruvate-kinase coupled assay was performed to measure the kinase activity of the proteins as described (<xref ref-type="bibr" rid="bib5">Barker et al., 1995</xref>), with minor modifications. The ATP concentration was kept at 1 mM in all the assays. The buffer used contains 150 mM NaCl, 10 mM MgCl<sub>2</sub>, 25 mM Tris, pH 7.5, 2 mM sodium vandate. The protein concentrations were kept at 1 μM for all Btk constructs. The peptide sequence is ERDINSLYDVSRMYVDPSEIN, which was derived from residues 746 to 766 of PLC-γ2. The <italic>K</italic><sub>m</sub> value for phosphorylated full-length Btk for this peptide is 925 ± 117 μM, and the peptide concentration was kept at 1 mM in all experiments. The reactions were performed in a 96-well plate and were monitored by SpectraMax (Molecular Devices, Sunnyvale CA). The ATP turn-over rate (v<sub>0</sub>: min<sup>−1</sup>) was calculated by fitting the data acquired from first 150 s using a linear regression model.</p></sec><sec id="s3-6"><title>Western blot</title><p>The levels of autophosphorylation of purified Btk samples were monitored using non-specific anti-phosphortyrosine antibody 4G10 (EMDMillipore). The total amount of Btk was monitored using coomassie-blue stained SDS-PAGE. For each set of experiments, 10 μl of each Btk sample was loaded on two 12% SDS-PAGE gels. The two gels were run at 250 V, 400 mA for 35 min at room temperature.</p><p>One gel was transferred to 50 ml fixing buffer containing 50% ethanol and 10% acetic acid and was heated for 30 s in a microwave. The gel is then transferred to 50 ml staining buffer that contains 5% ethanol, 7.5% acetic acid, and 0.00025% coomassie brilliant blue R-250 and was heated for another 30 s in a microwave. The gel was then left to cool at room temperature in the staining buffer on a rocker for 1 hr and was then imaged using ImageLab (Bio-Rad, Hercules CA).</p><p>The other gel was transferred into western blot transfer buffer that contains 25 mM Tris at pH 7.4, 192 mM glycine, and 20% methanol and was incubated at room temperature for 15 min. Protein samples were then transferred to PVDF membranes from the gel using the semi-dry transfer device TRANS-BLOT (Bio-Rad). The membranes were then blocked for 1 hr in TBST buffer (20 mM Tris pH 7.5, 150 mM NaCl, 0.1% Tween-20) supplemented with 5% dry milk, and incubated with primary antibody 4G10 (1:2000 dilution) at 4°C overnight. The membranes were then washed three times in TBST buffer, and incubated with HRP-linked anti-mouse IgG antibody (1:5000 dilution) in TBST buffer at room temperature for 1 hr. The membranes were then washed three times in TBST buffer, incubated with 0.5 ml WesternBright Quantum (Advansta, Menlo Park CA) for 1 min, and were imaged using ImageLab (Bio-Rad). The western blots were reproduced at least three times and the most representative ones were chose to present.</p></sec><sec id="s3-7"><title>Small unilamellar vesicle preparation</title><p>Three lipids, 18:1 DOPS, 18:1 (Δ9-Cis)(DOPC), and 18:1 PI(3,4,5) P<sub>3</sub> (Avanti, Alabaster AL) were dissolved in chloroform and stored at −20°C. For liposome preparations, the three lipids are mixed in a test tube at the desired molar ratio (10:75:5); chloroform was evaporated under a nitrogen atmosphere for 15 min; the samples were transferred to a vacuum desiccator and dried overnight at room temperature. Dry films were hydrated in buffer containing 25 mM Tris-HCl (pH 7.4) and 100 mM NaCl to a concentration of 10 mg/ml.</p><p>The hydrated liposomes are heterogeneous in size and the diameters of the liposomes vary from ∼50 nm to ≥ 1 μm. To prepare small unilamellar vesicles, hydrated liposomes were subject to seven freeze–thaw cycles using liquid nitrogen, followed by extrusion through 100-nm filters (Avestin, Canada). The liposomes prepared using this method have diameters around 100 nm, as measured using negative staining electron microscopy (data not shown).</p></sec><sec id="s3-8"><title>Isothermal titration calorimetry</title><p>The isothermal titration calorimetry experiments were performed using MicroCal-autoITC 200 (GE Healthcare). Various Btk samples are diluted in the binding buffer containing 150 mM NaCl, 25 mM Tris, pH 7.5, and 5% glycerol to a final concentration of 20 μM. IP<sub>4</sub> and IP<sub>6</sub> were diluted using the same buffer to a final concentration of 300 μM. Each set of ITC experiments included three samples: 420 μl of Btk protein sample in the cell, 150 μl of IP<sub>4</sub> or IP<sub>6</sub> at a concentration 300 μM in the syringe, and 500 μl of binding buffer. All samples are stored at 4°C before the titration experiments.</p><p>The ITC experiments were performed at 20°C. An initial injection of 0.5 μl was excluded from data analysis, followed by 14 injections of 3 μl each, separated by 180 s with a filter period of 5 s. The protein solution was stirred at 500 rpm over the course of titration. Titration curves were fit with a one-site binding model. The three fitting parameters are stoichiometry, N, association constant, K<sub>a</sub> and binding enthalpy, <italic>Δ</italic>H. The binding entropy is then calculated using formula: <italic>Δ</italic>S = (<italic>Δ</italic>H + RTlnK<sub>a</sub>)/T. Thermodynamic parameters for various Btk constructs binding to IP<sub>4</sub> and IP<sub>6</sub> are listed in <xref ref-type="table" rid="tbl1">Table 1</xref>.</p></sec><sec id="s3-9"><title>Molecular dynamics simulations</title><p>Molecular dynamics trajectories were generated using the Gromacs 4.6.2 package (<xref ref-type="bibr" rid="bib55">Pronk et al., 2013</xref>) using the ff99SB-ILDN force field (<xref ref-type="bibr" rid="bib41">Lindorff-Larsen et al., 2010</xref>). All simulations were in water, using the TIP3P water model; appropriate counterions (Na<sup>+</sup> and Cl<sup>−</sup>) were added to neutralize the net charges. After initial energy minimization, the systems were subjected to 100 ps of constant number, volume and temperature (NVT) equilibration, during which the system was heated to 300 K. This was followed by a short equilibration at constant number, pressure, and temperature (NPT, 100 ps). Finally, the production simulations were performed under NPT conditions, with v-rescale thermostats in Gromacs 4.6.2, respectively, in the absence of positional restraints. Periodic boundary conditions were imposed, and particle-mesh Ewald summations were used for long-range electrostatics and the van der Waals cut-off is set at 10 Å. A time step of 2 fs was employed and the structures were stored every 2 ps. His 143, Cys 154, Cys 155, and Cys 165, which coordinate Zn<sup>2+</sup> in the PH domain were set to be deprotonated. No additional positional restrains are applied to the Zn<sup>2+</sup> ion, and its sp<sup>3</sup> tetrahedral coordination remains intact during all MD simulations.</p><p>The visual molecular dynamics (VMD) analysis toolkit (<xref ref-type="bibr" rid="bib28">Humphrey et al., 1996</xref>) was used to make some of the root mean square deviation (RMSD) measurements, others were done using PyMol.</p></sec><sec id="s3-10"><title>Homology modeling</title><p>The active conformation of the Btk kinase domain was modeled based on that of the Lck kinase domain (PDB: 3LCK) (<xref ref-type="bibr" rid="bib62">Sicheri et al., 1997</xref>), using Modeller (<xref ref-type="bibr" rid="bib22">Eswar et al., 2006</xref>). The sequence of the kinase domains of Lck and Btk were aligned by ClustalW (<xref ref-type="bibr" rid="bib38">Larkin et al., 2007</xref>). We chose the model with the lowest Discrete Optimized Protein Energy (DOPE: −0.84) as representative of the active conformation of Btk.</p></sec><sec id="s3-11"><title>Estimate of membrane-bound Btk concentration</title><p>We estimated the effective concentration (<italic>C</italic>) of Btk on a lipid vesicle by the following equation:<disp-formula id="equ1"><mml:math id="m1"><mml:mrow><mml:mi>C</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mi>N</mml:mi><mml:mrow><mml:mi>V</mml:mi><mml:mo>×</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula></p><p><italic>N</italic> is the number of Btk molecules on a lipid vesicle, <italic>N</italic><sub><italic>a</italic></sub> is the Avogadro number, and <italic>V</italic> is the effective volume in which Btk moves on a lipid <inline-formula><mml:math id="inf1"><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mi>A</mml:mi><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:math></inline-formula> vesicle. An estimate for <italic>V</italic> is given by:<disp-formula id="equ2"><mml:math id="m2"><mml:mrow><mml:mi>V</mml:mi><mml:mo>=</mml:mo><mml:mi>A</mml:mi><mml:mo>×</mml:mo><mml:mi>L</mml:mi><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula></p><p>Here, <italic>A</italic> is the surface area of a lipid vesicle and <italic>L</italic> is the length of a Btk molecule, ∼ 100 Å, as measured from the composite model of full-length Btk. Assuming all the PIP<sub>3</sub> molecules (molar fraction, <italic>f</italic>) are bound to Btk, then,<disp-formula id="equ3"><mml:math id="m3"><mml:mrow><mml:mi>N</mml:mi><mml:mo>=</mml:mo><mml:mi>f</mml:mi><mml:mo>×</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula>where <italic>N</italic><sub><italic>0</italic></sub> is the total number of lipids on a vesicle. This is given by,<disp-formula id="equ4"><mml:math id="m4"><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mi>A</mml:mi><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula>in which <italic>A</italic><sub><italic>0</italic></sub> is the surface area of a lipid molecule. We assume all lipids have the same surface area for their headgroups, which is roughly 0.6 nm<sup>2</sup> (<xref ref-type="bibr" rid="bib25">Gulik-Krzywicki et al., 1967</xref>). Therefore C is given by:<disp-formula id="equ5"><mml:math id="m5"><mml:mrow><mml:mi>C</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mi>N</mml:mi><mml:mrow><mml:mi>V</mml:mi><mml:mo>×</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>f</mml:mi><mml:mo>×</mml:mo><mml:mfrac><mml:mi>A</mml:mi><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mfrac></mml:mrow><mml:mrow><mml:mi>A</mml:mi><mml:mo>×</mml:mo><mml:mi>L</mml:mi><mml:mo>×</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mi>f</mml:mi><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>×</mml:mo><mml:mi>L</mml:mi><mml:mo>×</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula></p><p>In our experiments, <italic>f</italic> = 0.05, A<sub>0</sub> = ∼60 Å<sup>2</sup>, N<sub>a</sub> = 6.03 × 10<sup>23</sup> mol<sup>−1</sup>, and <italic>L</italic> = ∼100 Å, giving a value of 12 mM for C.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank Arthur Weiss, Terri Kadlecek, William Degrado, and Manasi Bhate at UCSF for helpful discussions and help with ongoing experiments; Kuriyan lab members, especially Jon Winger, Jeff Iwig, and Qingrong Yan, for helpful discussions; Ross Wilson (UC Berkeley) for training on micro-ITC 200, David King (HHMI) for synthesizing peptides; Tony Iavarone (QB3) for mass spectrometry analysis; Tiago Barros and the beamline staff at ALS 8.2.1/8.2.2 for advice on data collection and structure refinement; Ming Lei, Wenqing Xu, and Michael Eck for contributions to the SH3-SH2-kinase crystallization and structure determination; Tiago Barros, Neel Shah, Meg Stratton, and Yongjian Huang for critically reading the manuscript.</p><p>This work was supported in part by NIH grant PO1 AI091580 to JK. QW is supported by the Cancer Research Institute-Irvington Institute Fellowship Program.</p></ack><sec id="s4" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="conflict" id="conf1"><p>SCH: Reviewing editor, <italic>eLife</italic>.</p></fn><fn fn-type="conflict" id="conf2"><p>JK: Senior editor, <italic>eLife.</italic></p></fn><fn fn-type="conflict" id="conf3"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>QW, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con2"><p>EMV, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con3"><p>LMN, Acquisition of data, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con4"><p>CER, Acquisition of data, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con5"><p>JAZ, Acquisition of data, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con6"><p>SCH, Conception and design, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con7"><p>JK, Conception and design, Analysis and interpretation of data, Drafting or revising the article</p></fn></fn-group></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>PD</given-names></name><name><surname>Grosse-Kunstleve</surname><given-names>RW</given-names></name><name><surname>Hung</surname><given-names>LW</given-names></name><name><surname>Ioerger</surname><given-names>TR</given-names></name><name><surname>McCoy</surname><given-names>AJ</given-names></name><name><surname>Moriarty</surname><given-names>NW</given-names></name><name><surname>Read</surname><given-names>RJ</given-names></name><name><surname>Sacchettini</surname><given-names>JC</given-names></name><name><surname>Sauter</surname><given-names>NK</given-names></name><name><surname>Terwilliger</surname><given-names>TC</given-names></name></person-group><year>2002</year><article-title>PHENIX: building new software for automated crystallographic structure determination</article-title><source>Acta Crystallographica Section D, Biological Crystallography</source><volume>58</volume><fpage>1948</fpage><lpage>1954</lpage><pub-id pub-id-type="doi">10.1107/S0907444902016657</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreotti</surname><given-names>AH</given-names></name><name><surname>Schwartzberg</surname><given-names>PL</given-names></name><name><surname>Joseph</surname><given-names>RE</given-names></name><name><surname>Berg</surname><given-names>LJ</given-names></name></person-group><year>2010</year><article-title>T-cell signaling regulated by the Tec family kinase, Itk</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>2</volume><fpage>a002287</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a002287</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banavali</surname><given-names>NK</given-names></name><name><surname>Roux</surname><given-names>B</given-names></name></person-group><year>2009</year><article-title>Flexibility and charge asymmetry in the activation loop of Src tyrosine kinases</article-title><source>Proteins</source><volume>74</volume><fpage>378</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.1002/prot.22153</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baraldi</surname><given-names>E</given-names></name><name><surname>Djinovic Carugo</surname><given-names>K</given-names></name><name><surname>Hyvönen</surname><given-names>M</given-names></name><name><surname>Surdo</surname><given-names>PL</given-names></name><name><surname>Riley</surname><given-names>AM</given-names></name><name><surname>Potter</surname><given-names>BV</given-names></name><name><surname>O'Brien</surname><given-names>R</given-names></name><name><surname>Ladbury</surname><given-names>JE</given-names></name><name><surname>Saraste</surname><given-names>M</given-names></name></person-group><year>1999</year><article-title>Structure of the PH domain from Bruton's tyrosine kinase in complex with inositol 1,3,4,5-tetrakisphosphate</article-title><source>Structure</source><volume>7</volume><fpage>449</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1016/S0969-2126(99)80057-4</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barker</surname><given-names>SC</given-names></name><name><surname>Kassel</surname><given-names>DB</given-names></name><name><surname>Weigl</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Luther</surname><given-names>MA</given-names></name><name><surname>Knight</surname><given-names>WB</given-names></name></person-group><year>1995</year><article-title>Characterization of pp60c-src tyrosine kinase activities using a continuous assay: autoactivation of the enzyme is an intermolecular autophosphorylation process</article-title><source>Biochemistry</source><volume>34</volume><fpage>14843</fpage><lpage>14851</lpage><pub-id pub-id-type="doi">10.1021/bi00045a027</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bence</surname><given-names>K</given-names></name><name><surname>Ma</surname><given-names>W</given-names></name><name><surname>Kozasa</surname><given-names>T</given-names></name><name><surname>Huang</surname><given-names>XY</given-names></name></person-group><year>1997</year><article-title>Direct stimulation of Bruton's tyrosine kinase by Gq-protein α-subunit</article-title><source>Nature</source><volume>389</volume><fpage>296</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1038/38520</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brasher</surname><given-names>BB</given-names></name><name><surname>Van Etten</surname><given-names>RA</given-names></name></person-group><year>2000</year><article-title>c-Abl has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines</article-title><source>The Journal of Biological Chemistry</source><volume>275</volume><fpage>35631</fpage><lpage>35637</lpage><pub-id pub-id-type="doi">10.1074/jbc.M005401200</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bricogne</surname><given-names>G</given-names></name><name><surname>Vonrhein</surname><given-names>C</given-names></name><name><surname>Flensburg</surname><given-names>C</given-names></name><name><surname>Schiltz</surname><given-names>M</given-names></name><name><surname>Paciorek</surname><given-names>W</given-names></name></person-group><year>2003</year><article-title>Generation, representation and flow of phase information in structure determination: recent developments in and around SHARP 2.0</article-title><source>Acta Crystallographica Section D, Biological Crystallography</source><volume>59</volume><fpage>2023</fpage><lpage>2030</lpage><pub-id pub-id-type="doi">10.1107/S0907444903017694</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunger</surname><given-names>AT</given-names></name></person-group><year>2007</year><article-title>Version 1.2 of the Crystallography and NMR system</article-title><source>Nature Protocols</source><volume>2</volume><fpage>2728</fpage><lpage>2733</lpage><pub-id pub-id-type="doi">10.1038/nprot.2007.406</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunger</surname><given-names>AT</given-names></name><name><surname>Adams</surname><given-names>PD</given-names></name><name><surname>Clore</surname><given-names>GM</given-names></name><name><surname>DeLano</surname><given-names>WL</given-names></name><name><surname>Gros</surname><given-names>P</given-names></name><name><surname>Grosse-Kunstleve</surname><given-names>RW</given-names></name><name><surname>Jiang</surname><given-names>JS</given-names></name><name><surname>Kuszewski</surname><given-names>J</given-names></name><name><surname>Nilges</surname><given-names>M</given-names></name><name><surname>Pannu</surname><given-names>NS</given-names></name><name><surname>Read</surname><given-names>RJ</given-names></name><name><surname>Rice</surname><given-names>LM</given-names></name><name><surname>Simonson</surname><given-names>T</given-names></name><name><surname>Warren</surname><given-names>GL</given-names></name></person-group><year>1998</year><article-title>Crystallography &amp; NMR system: a new software suite for macromolecular structure determination</article-title><source>Acta Crystallographica Section D, Biological Crystallography</source><volume>54</volume><fpage>905</fpage><lpage>921</lpage><pub-id pub-id-type="doi">10.1107/S0907444998003254</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calleja</surname><given-names>V</given-names></name><name><surname>Laguerre</surname><given-names>M</given-names></name><name><surname>Parker</surname><given-names>PJ</given-names></name><name><surname>Larijani</surname><given-names>B</given-names></name></person-group><year>2009</year><article-title>Role of a novel PH-kinase domain interface in PKB/Akt regulation: structural mechanism for allosteric inhibition</article-title><source>PLOS Biology</source><volume>7</volume><fpage>e17</fpage><pub-id pub-id-type="doi">10.1371/journal.pbio.1000017</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cambier</surname><given-names>JC</given-names></name><name><surname>Bedzyk</surname><given-names>W</given-names></name><name><surname>Campbell</surname><given-names>K</given-names></name><name><surname>Chien</surname><given-names>N</given-names></name><name><surname>Friedrich</surname><given-names>J</given-names></name><name><surname>Harwood</surname><given-names>A</given-names></name><name><surname>Jensen</surname><given-names>W</given-names></name><name><surname>Pleiman</surname><given-names>C</given-names></name><name><surname>Clark</surname><given-names>MR</given-names></name></person-group><year>1993</year><article-title>The B-cell antigen receptor: structure and function of primary, secondary, tertiary and quaternary components</article-title><source>Immunological Reviews</source><volume>132</volume><fpage>85</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1111/j.1600-065X.1993.tb00838.x</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakraborty</surname><given-names>A</given-names></name><name><surname>Koldobskiy</surname><given-names>MA</given-names></name><name><surname>Bello</surname><given-names>NT</given-names></name><name><surname>Maxwell</surname><given-names>M</given-names></name><name><surname>Potter</surname><given-names>JJ</given-names></name><name><surname>Juluri</surname><given-names>KR</given-names></name><name><surname>Maag</surname><given-names>D</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>AS</given-names></name><name><surname>Dailey</surname><given-names>MJ</given-names></name><name><surname>Saleh</surname><given-names>M</given-names></name><name><surname>Snowman</surname><given-names>AM</given-names></name><name><surname>Moran</surname><given-names>TH</given-names></name><name><surname>Mezey</surname><given-names>E</given-names></name><name><surname>Snyder</surname><given-names>SH</given-names></name></person-group><year>2010</year><article-title>Inositol pyrophosphates inhibit akt signaling, thereby regulating Insulin sensitivity and weight gain</article-title><source>Cell</source><volume>143</volume><fpage>897</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.11.032</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>DH</given-names></name><name><surname>Morita</surname><given-names>CT</given-names></name><name><surname>Weiss</surname><given-names>A</given-names></name></person-group><year>1998</year><article-title>The Syk family of protein tyrosine kinases in T-cell activation and development</article-title><source>Immunological Reviews</source><volume>165</volume><fpage>167</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1111/j.1600-065X.1998.tb01238.x</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cowtan</surname><given-names>KD</given-names></name><name><surname>Main</surname><given-names>P</given-names></name></person-group><year>1993</year><article-title>Improvement of macromolecular electron-density maps by the simultaneous application of real and reciprocal space constraints</article-title><source>Acta Crystallographica Section D, Biological Crystallography</source><volume>49</volume><fpage>148</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1107/S0907444992007698</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dal Porto</surname><given-names>JM</given-names></name><name><surname>Gauld</surname><given-names>SB</given-names></name><name><surname>Merrell</surname><given-names>KT</given-names></name><name><surname>Mills</surname><given-names>D</given-names></name><name><surname>Pugh-Bernard</surname><given-names>AE</given-names></name><name><surname>Cambier</surname><given-names>J</given-names></name></person-group><year>2004</year><article-title>B cell antigen receptor signaling 101</article-title><source>Molecular Immunology</source><volume>41</volume><fpage>599</fpage><lpage>613</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2004.04.008</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Braekeleer</surname><given-names>E</given-names></name><name><surname>Douet-Guilbert</surname><given-names>N</given-names></name><name><surname>Rowe</surname><given-names>D</given-names></name><name><surname>Bown</surname><given-names>N</given-names></name><name><surname>Morel</surname><given-names>F</given-names></name><name><surname>Berthou</surname><given-names>C</given-names></name><name><surname>Férec</surname><given-names>C</given-names></name><name><surname>De Braekeleer</surname><given-names>M</given-names></name></person-group><year>2011</year><article-title>ABL1 fusion genes in hematological malignancies: a review</article-title><source>European Journal of Haematology</source><volume>86</volume><fpage>361</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0609.2011.01586.x</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Paolo</surname><given-names>JA</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Balazs</surname><given-names>M</given-names></name><name><surname>Barbosa</surname><given-names>J</given-names></name><name><surname>Barck</surname><given-names>KH</given-names></name><name><surname>Bravo</surname><given-names>BJ</given-names></name><name><surname>Carano</surname><given-names>RA</given-names></name><name><surname>Darrow</surname><given-names>J</given-names></name><name><surname>Davies</surname><given-names>DR</given-names></name><name><surname>DeForge</surname><given-names>LE</given-names></name><name><surname>Diehl</surname><given-names>L</given-names></name><name><surname>Ferrando</surname><given-names>R</given-names></name><name><surname>Gallion</surname><given-names>SL</given-names></name><name><surname>Giannetti</surname><given-names>AM</given-names></name><name><surname>Gribling</surname><given-names>P</given-names></name><name><surname>Hurez</surname><given-names>V</given-names></name><name><surname>Hymowitz</surname><given-names>SG</given-names></name><name><surname>Jones</surname><given-names>R</given-names></name><name><surname>Kropf</surname><given-names>JE</given-names></name><name><surname>Lee</surname><given-names>WP</given-names></name><name><surname>Maciejewski</surname><given-names>PM</given-names></name><name><surname>Mitchell</surname><given-names>SA</given-names></name><name><surname>Rong</surname><given-names>H</given-names></name><name><surname>Staker</surname><given-names>BL</given-names></name><name><surname>Whitney</surname><given-names>JA</given-names></name><name><surname>Yeh</surname><given-names>S</given-names></name><name><surname>Young</surname><given-names>WB</given-names></name><name><surname>Yu</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Reif</surname><given-names>K</given-names></name><name><surname>Currie</surname><given-names>KS</given-names></name></person-group><year>2011</year><article-title>Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis</article-title><source>Nature Chemical Biology</source><volume>7</volume><fpage>41</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1038/nchembio.481</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolinsky</surname><given-names>TJ</given-names></name><name><surname>Czodrowski</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Nielsen</surname><given-names>JE</given-names></name><name><surname>Jensen</surname><given-names>JH</given-names></name><name><surname>Klebe</surname><given-names>G</given-names></name><name><surname>Baker</surname><given-names>NA</given-names></name></person-group><year>2007</year><article-title>PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations</article-title><source>Nucleic Acids Research</source><volume>35</volume><fpage>W522</fpage><lpage>W525</lpage><pub-id pub-id-type="doi">10.1093/nar/gkm276</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolinsky</surname><given-names>TJ</given-names></name><name><surname>Nielsen</surname><given-names>JE</given-names></name><name><surname>McCammon</surname><given-names>JA</given-names></name><name><surname>Baker</surname><given-names>NA</given-names></name></person-group><year>2004</year><article-title>PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations</article-title><source>Nucleic Acids Research</source><volume>32</volume><fpage>W665</fpage><lpage>W667</lpage><pub-id pub-id-type="doi">10.1093/nar/gkh381</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emsley</surname><given-names>P</given-names></name><name><surname>Cowtan</surname><given-names>K</given-names></name></person-group><year>2004</year><article-title>Coot: model-building tools for molecular graphics</article-title><source>Acta Crystallographica Section D, Biological Crystallography</source><volume>60</volume><fpage>2126</fpage><lpage>2132</lpage><pub-id pub-id-type="doi">10.1107/S0907444904019158</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Eswar</surname><given-names>N</given-names></name><name><surname>Webb</surname><given-names>B</given-names></name><name><surname>Marti Renom</surname><given-names>MA</given-names></name><name><surname>Madhusudhan</surname><given-names>MS</given-names></name><name><surname>Eramian</surname><given-names>D</given-names></name><name><surname>Shen</surname><given-names>MY</given-names></name><name><surname>Pieper</surname><given-names>U</given-names></name><name><surname>Sali</surname><given-names>A</given-names></name></person-group><year>2006</year><source>Comparative protein structure modeling using modeller</source><publisher-loc>Hoboken, NJ, USA</publisher-loc><publisher-name>John Wiley &amp; Sons, Inc</publisher-name></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>KM</given-names></name><name><surname>Lemmon</surname><given-names>MA</given-names></name><name><surname>Schlessinger</surname><given-names>J</given-names></name><name><surname>Sigler</surname><given-names>PB</given-names></name></person-group><year>1995</year><article-title>Structure of the high affinity complex of inositol trisphosphate with a phospholipase C pleckstrin homology domain</article-title><source>Cell</source><volume>83</volume><fpage>1037</fpage><lpage>1046</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(95)90219-8</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filippakopoulos</surname><given-names>P</given-names></name><name><surname>Kofler</surname><given-names>M</given-names></name><name><surname>Hantschel</surname><given-names>O</given-names></name><name><surname>Gish</surname><given-names>GD</given-names></name><name><surname>Grebien</surname><given-names>F</given-names></name><name><surname>Salah</surname><given-names>E</given-names></name><name><surname>Neudecker</surname><given-names>P</given-names></name><name><surname>Kay</surname><given-names>LE</given-names></name><name><surname>Turk</surname><given-names>BE</given-names></name><name><surname>Superti-Furga</surname><given-names>G</given-names></name><name><surname>Pawson</surname><given-names>T</given-names></name><name><surname>Knapp</surname><given-names>S</given-names></name></person-group><year>2008</year><article-title>Structural coupling of SH2-kinase domains links Fes and abl substrate recognition and kinase activation</article-title><source>Cell</source><volume>134</volume><fpage>793</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.07.047</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gulik-Krzywicki</surname><given-names>T</given-names></name><name><surname>Rivas</surname><given-names>E</given-names></name><name><surname>Luzzati</surname><given-names>V</given-names></name></person-group><year>1967</year><article-title>Structure et polymorphisme des lipides: Étude par diffraction des rayons X du système formé de lipides de mitochondries de coeur de boeuf et d'Eau</article-title><source>Journal of Molecular Biology</source><volume>27</volume><fpage>303</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1016/0022-2836(67)90022-8</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansson</surname><given-names>H</given-names></name><name><surname>Mattsson</surname><given-names>PT</given-names></name><name><surname>Allard</surname><given-names>P</given-names></name><name><surname>Haapaniemi</surname><given-names>P</given-names></name><name><surname>Vihinen</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>CI</given-names></name><name><surname>Hard</surname><given-names>T</given-names></name></person-group><year>1998</year><article-title>Solution structure of the SH3 domain from Bruton's tyrosine kinase</article-title><source>Biochemistry</source><volume>37</volume><fpage>2912</fpage><lpage>2924</lpage><pub-id pub-id-type="doi">10.1021/bi972409f</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>YH</given-names></name><name><surname>Grasis</surname><given-names>JA</given-names></name><name><surname>Miller</surname><given-names>AT</given-names></name><name><surname>Xu</surname><given-names>R</given-names></name><name><surname>Soonthornvacharin</surname><given-names>S</given-names></name><name><surname>Andreotti</surname><given-names>AH</given-names></name><name><surname>Tsoukas</surname><given-names>CD</given-names></name><name><surname>Cooke</surname><given-names>MP</given-names></name><name><surname>Sauer</surname><given-names>K</given-names></name></person-group><year>2007</year><article-title>Positive regulation of Itk PH domain function by soluble IP4</article-title><source>Science</source><volume>316</volume><fpage>886</fpage><lpage>889</lpage><pub-id pub-id-type="doi">10.1126/science.1138684</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Humphrey</surname><given-names>W</given-names></name><name><surname>Dalke</surname><given-names>A</given-names></name><name><surname>Schulten</surname><given-names>K</given-names></name></person-group><year>1996</year><article-title>VMD: visual molecular dynamics</article-title><source>Journal of Molecular Graphics</source><volume>14</volume><fpage>33</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1016/0263-7855(96)00018-5</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hyvönen</surname><given-names>M</given-names></name><name><surname>Macias</surname><given-names>MJ</given-names></name><name><surname>Nilges</surname><given-names>M</given-names></name><name><surname>Oschkinat</surname><given-names>H</given-names></name><name><surname>Saraste</surname><given-names>M</given-names></name><name><surname>Wilmanns</surname><given-names>M</given-names></name></person-group><year>1995</year><article-title>Structure of the binding site for inositol phosphates in a PH domain</article-title><source>The EMBO Journal</source><volume>14</volume><fpage>4676</fpage><lpage>4685</lpage></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hyvönen</surname><given-names>M</given-names></name><name><surname>Saraste</surname><given-names>M</given-names></name></person-group><year>1997</year><article-title>Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: molecular explanations for X‐linked agammaglobulinaemia</article-title><source>The EMBO Journal</source><volume>16</volume><fpage>3396</fpage><lpage>3404</lpage><pub-id pub-id-type="doi">10.1093/emboj/16.12.3396</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irvine</surname><given-names>RF</given-names></name><name><surname>Schell</surname><given-names>MJ</given-names></name></person-group><year>2001</year><article-title>Back in the water: the return of the inositol phosphates</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>2</volume><fpage>327</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1038/35073015</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jefferies</surname><given-names>CA</given-names></name><name><surname>Doyle</surname><given-names>S</given-names></name><name><surname>Brunner</surname><given-names>C</given-names></name><name><surname>Dunne</surname><given-names>A</given-names></name><name><surname>Brint</surname><given-names>E</given-names></name><name><surname>Wietek</surname><given-names>C</given-names></name><name><surname>Walch</surname><given-names>E</given-names></name><name><surname>Wirth</surname><given-names>T</given-names></name><name><surname>O'Neill</surname><given-names>LA</given-names></name></person-group><year>2003</year><article-title>Bruton's tyrosine kinase is a Toll/Interleukin-1 receptor domain-binding protein that participates in nuclear factor κB activation by Toll-like receptor 4</article-title><source>The Journal of Biological Chemistry</source><volume>278</volume><fpage>26258</fpage><lpage>26264</lpage><pub-id pub-id-type="doi">10.1074/jbc.M301484200</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>TA</given-names></name><name><surname>Zou</surname><given-names>JY</given-names></name><name><surname>Cowan</surname><given-names>SW</given-names></name><name><surname>Kjeldgaard</surname><given-names>M</given-names></name></person-group><year>1991</year><article-title>Improved methods for building protein models in electron density maps and the location of errors in these models</article-title><source>Acta Crystallographica Section A, Foundations of Crystallography</source><volume>47</volume><fpage>110</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1107/S0108767390010224</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joseph</surname><given-names>RE</given-names></name><name><surname>Kleino</surname><given-names>I</given-names></name><name><surname>Wales</surname><given-names>TE</given-names></name><name><surname>Xie</surname><given-names>Q</given-names></name><name><surname>Fulton</surname><given-names>DB</given-names></name><name><surname>Engen</surname><given-names>JR</given-names></name><name><surname>Berg</surname><given-names>LJ</given-names></name><name><surname>Andreotti</surname><given-names>AH</given-names></name></person-group><year>2013</year><article-title>Activation loop dynamics determine the different catalytic efficiencies of B cell- and T cell-specific tec kinases</article-title><source>Science Signaling</source><volume>6</volume><fpage>ra76</fpage><pub-id pub-id-type="doi">10.1126/scisignal.2004298</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawakami</surname><given-names>Y</given-names></name><name><surname>Yao</surname><given-names>L</given-names></name><name><surname>Miura</surname><given-names>T</given-names></name><name><surname>Tsukada</surname><given-names>S</given-names></name><name><surname>Witte</surname><given-names>ON</given-names></name><name><surname>Kawakami</surname><given-names>T</given-names></name></person-group><year>1994</year><article-title>Tyrosine phosphorylation and activation of Bruton tyrosine kinase upon Fc epsilon RI cross-linking</article-title><source>Molecular and Cellular Biology</source><volume>14</volume><fpage>5108</fpage><lpage>5113</lpage></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurosaki</surname><given-names>T</given-names></name></person-group><year>2011</year><article-title>Regulation of BCR signaling</article-title><source>Molecular Immunology</source><volume>48</volume><fpage>1287</fpage><lpage>1291</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2010.12.007</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laederach</surname><given-names>A</given-names></name><name><surname>Cradic</surname><given-names>KW</given-names></name><name><surname>Brazin</surname><given-names>KN</given-names></name><name><surname>Zamoon</surname><given-names>J</given-names></name><name><surname>Fulton</surname><given-names>DB</given-names></name><name><surname>Huang</surname><given-names>XY</given-names></name><name><surname>Andreotti</surname><given-names>AH</given-names></name></person-group><year>2002</year><article-title>Competing modes of self‐association in the regulatory domains of Bruton's tyrosine kinase: intramolecular contact versus asymmetric homodimerization</article-title><source>Protein Science</source><volume>11</volume><fpage>36</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1110/ps.ps.26702</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larkin</surname><given-names>MA</given-names></name><name><surname>Blackshields</surname><given-names>G</given-names></name><name><surname>Brown</surname><given-names>NP</given-names></name><name><surname>Chenna</surname><given-names>R</given-names></name><name><surname>McGettigan</surname><given-names>PA</given-names></name><name><surname>McWilliam</surname><given-names>H</given-names></name><name><surname>Valentin</surname><given-names>F</given-names></name><name><surname>Wallace</surname><given-names>IM</given-names></name><name><surname>Wilm</surname><given-names>A</given-names></name><name><surname>Lopez</surname><given-names>R</given-names></name><name><surname>Thompson</surname><given-names>JD</given-names></name><name><surname>Gibson</surname><given-names>TJ</given-names></name><name><surname>Higgins</surname><given-names>DG</given-names></name></person-group><year>2007</year><article-title>Clustal W and Clustal X version 2.0</article-title><source>Bioinformatics</source><volume>23</volume><fpage>2947</fpage><lpage>2948</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btm404</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>WK</given-names></name><name><surname>Son</surname><given-names>SH</given-names></name><name><surname>Jin</surname><given-names>BS</given-names></name><name><surname>Na</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>K-H</given-names></name><name><surname>Kim</surname><given-names>EE</given-names></name><name><surname>Yu</surname><given-names>YG</given-names></name><name><surname>Lee</surname><given-names>HH</given-names></name></person-group><year>2013</year><article-title>Structural and functional insights into the regulation mechanism of CK2 by IP6 and the intrinsically disordered protein Nopp140</article-title><source>Proceedings of the National Academy of Sciences of USA</source><volume>110</volume><fpage>19360</fpage><lpage>19365</lpage><pub-id pub-id-type="doi">10.1073/pnas.1304670110</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemmon</surname><given-names>MA</given-names></name></person-group><year>2008</year><article-title>Membrane recognition by phospholipid-binding domains</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>9</volume><fpage>99</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1038/nrm2328</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindorff-Larsen</surname><given-names>K</given-names></name><name><surname>Piana</surname><given-names>S</given-names></name><name><surname>Palmo</surname><given-names>K</given-names></name><name><surname>Maragakis</surname><given-names>P</given-names></name><name><surname>Klepeis</surname><given-names>JL</given-names></name><name><surname>Dror</surname><given-names>RO</given-names></name><name><surname>Shaw</surname><given-names>DE</given-names></name></person-group><year>2010</year><article-title>Improved side-chain torsion potentials for the Amber ff99SB protein force field</article-title><source>Proteins</source><volume>78</volume><fpage>1950</fpage><lpage>1958</lpage><pub-id pub-id-type="doi">10.1002/prot.22711</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindvall</surname><given-names>JM</given-names></name><name><surname>Blomberg</surname><given-names>KE</given-names></name><name><surname>Väliaho</surname><given-names>J</given-names></name><name><surname>Vargas</surname><given-names>L</given-names></name><name><surname>Heinonen</surname><given-names>JE</given-names></name><name><surname>Berglöf</surname><given-names>A</given-names></name><name><surname>Mohamed</surname><given-names>AJ</given-names></name><name><surname>Nore</surname><given-names>BF</given-names></name><name><surname>Vihinen</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>CI</given-names></name></person-group><year>2005</year><article-title>Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling</article-title><source>Immunological Reviews</source><volume>203</volume><fpage>200</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1111/j.0105-2896.2005.00225.x</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maignan</surname><given-names>S</given-names></name><name><surname>Guilloteau</surname><given-names>JP</given-names></name><name><surname>Fromage</surname><given-names>N</given-names></name><name><surname>Arnoux</surname><given-names>B</given-names></name></person-group><year>1995</year><article-title>Crystal structure of the mammalian Grb2 adaptor</article-title><source>Science</source><volume>268</volume><fpage>291</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1126/science.7716522</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Márquez</surname><given-names>JA</given-names></name><name><surname>Smith</surname><given-names>CIE</given-names></name><name><surname>Petoukhov</surname><given-names>MV</given-names></name><name><surname>Surdo</surname><given-names>PL</given-names></name><name><surname>Mattsson</surname><given-names>PT</given-names></name><name><surname>Knekt</surname><given-names>M</given-names></name><name><surname>Westlund</surname><given-names>A</given-names></name><name><surname>Scheffzek</surname><given-names>K</given-names></name><name><surname>Saraste</surname><given-names>M</given-names></name><name><surname>Svergun</surname><given-names>DI</given-names></name></person-group><year>2003</year><article-title>Conformation of full–length Bruton tyrosine kinase (Btk) from synchrotron X–ray solution scattering</article-title><source>The EMBO Journal</source><volume>22</volume><fpage>4616</fpage><lpage>4624</lpage><pub-id pub-id-type="doi">10.1093/emboj/cdg448</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Middendorp</surname><given-names>S</given-names></name><name><surname>Dingjan</surname><given-names>GM</given-names></name><name><surname>Maas</surname><given-names>A</given-names></name><name><surname>Dahlenborg</surname><given-names>K</given-names></name><name><surname>Hendriks</surname><given-names>RW</given-names></name></person-group><year>2003</year><article-title>Function of Bruton's tyrosine kinase during B cell development is partially independent of its catalytic activity</article-title><source>The Journal of Immunology</source><volume>171</volume><fpage>5988</fpage><lpage>5996</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.171.11.5988</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millard</surname><given-names>CJ</given-names></name><name><surname>Watson</surname><given-names>PJ</given-names></name><name><surname>Celardo</surname><given-names>I</given-names></name><name><surname>Gordiyenko</surname><given-names>Y</given-names></name><name><surname>Cowley</surname><given-names>SM</given-names></name><name><surname>Robinson</surname><given-names>CV</given-names></name><name><surname>Fairall</surname><given-names>L</given-names></name><name><surname>Schwabe</surname><given-names>JWR</given-names></name></person-group><year>2013</year><article-title>Class I HDACs share a common mechanism of regulation by inositol phosphates</article-title><source>Molecular Cell</source><volume>51</volume><fpage>57</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2013.05.020</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moarefi</surname><given-names>I</given-names></name><name><surname>LaFevre-Bernt</surname><given-names>M</given-names></name><name><surname>Sicheri</surname><given-names>F</given-names></name><name><surname>Huse</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>C-H</given-names></name><name><surname>Kuriyan</surname><given-names>J</given-names></name><name><surname>Miller</surname><given-names>WT</given-names></name></person-group><year>1997</year><article-title>Activation of the Sire-family tyrosine kinase Hck by SH3 domain displacement</article-title><source>Nature</source><volume>385</volume><fpage>650</fpage><lpage>653</lpage><pub-id pub-id-type="doi">10.1038/385650a0</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrogh</surname><given-names>LM</given-names></name><name><surname>Hinshelwood</surname><given-names>S</given-names></name><name><surname>Costello</surname><given-names>P</given-names></name><name><surname>Cory</surname><given-names>GO</given-names></name><name><surname>Kinnon</surname><given-names>C</given-names></name></person-group><year>1999</year><article-title>The SH3 domain of Bruton's tyrosine kinase displays altered ligand binding properties when auto‐phosphorylated in vitro</article-title><source>European Journal of Immunology</source><volume>29</volume><fpage>2269</fpage><lpage>2279</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1521-4141(199907)29:07&lt;2269::AID-IMMU2269&gt;3.0.CO;2-#</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mócsai</surname><given-names>A</given-names></name><name><surname>Ruland</surname><given-names>J</given-names></name><name><surname>Tybulewicz</surname><given-names>V</given-names></name></person-group><year>2010</year><article-title>The SYK tyrosine kinase: a crucial player in diverse biological functions</article-title><source>Nature Reviews Immunology</source><volume>10</volume><fpage>387</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1038/nri2765</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Zikherman</surname><given-names>J</given-names></name><name><surname>Parameswaran</surname><given-names>R</given-names></name><name><surname>Kadlecek</surname><given-names>TA</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Au-Yeung</surname><given-names>B</given-names></name><name><surname>Ploegh</surname><given-names>H</given-names></name><name><surname>Kuriyan</surname><given-names>J</given-names></name><name><surname>Das</surname><given-names>J</given-names></name><name><surname>Weiss</surname><given-names>A</given-names></name></person-group><year>2013</year><article-title>Monovalent and multivalent ligation of the B cell receptor exhibit differential dependence upon Syk and Src family kinases</article-title><source>Science Signaling</source><volume>6</volume><fpage>ra1</fpage><pub-id pub-id-type="doi">10.1126/scisignal.2003220</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagar</surname><given-names>B</given-names></name><name><surname>Hantschel</surname><given-names>O</given-names></name><name><surname>Seeliger</surname><given-names>M</given-names></name><name><surname>Davies</surname><given-names>JM</given-names></name><name><surname>Weis</surname><given-names>WI</given-names></name><name><surname>Superti-Furga</surname><given-names>G</given-names></name><name><surname>Kuriyan</surname><given-names>J</given-names></name></person-group><year>2006</year><article-title>Organization of the SH3-SH2 Unit in active and inactive forms of the c-Abl tyrosine kinase</article-title><source>Molecular Cell</source><volume>21</volume><fpage>787</fpage><lpage>798</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2006.01.035</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagar</surname><given-names>B</given-names></name><name><surname>Hantschel</surname><given-names>O</given-names></name><name><surname>Young</surname><given-names>MA</given-names></name><name><surname>Scheffzek</surname><given-names>K</given-names></name><name><surname>Veach</surname><given-names>D</given-names></name><name><surname>Bornmann</surname><given-names>W</given-names></name><name><surname>Clarkson</surname><given-names>B</given-names></name><name><surname>Superti-Furga</surname><given-names>G</given-names></name><name><surname>Kuriyan</surname><given-names>J</given-names></name></person-group><year>2003</year><article-title>Structural basis for the autoinhibition of c-Abl tyrosine kinase</article-title><source>Cell</source><volume>112</volume><fpage>859</fpage><lpage>871</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(03)00194-6</pub-id></element-citation></ref><ref id="bib52a"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Otwinowski</surname><given-names>Z</given-names></name><name><surname>Minor</surname><given-names>W</given-names></name></person-group><year>1997</year><article-title>Processing of X-ray Diffraction Data Collected in Oscillation Mode</article-title><person-group person-group-type="editor"><name><surname>Carter</surname><given-names>CW</given-names><suffix>Jr</suffix></name><name><surname>Sweet</surname><given-names>RM</given-names></name></person-group><source>Methods in Enzymology, Volume 276: Macromolecular Crystallography, part A</source><fpage>307</fpage><lpage>326</lpage></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozkirimli</surname><given-names>E</given-names></name><name><surname>Post</surname><given-names>CB</given-names></name></person-group><year>2006</year><article-title>Src kinase activation: a switched electrostatic network</article-title><source>Protein Science</source><volume>15</volume><fpage>1051</fpage><lpage>1062</lpage><pub-id pub-id-type="doi">10.1110/ps.051999206</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>H</given-names></name><name><surname>Wahl</surname><given-names>MI</given-names></name><name><surname>Afar</surname><given-names>DE</given-names></name><name><surname>Turck</surname><given-names>CW</given-names></name><name><surname>Rawlings</surname><given-names>DJ</given-names></name><name><surname>Tam</surname><given-names>C</given-names></name><name><surname>Scharenberg</surname><given-names>AM</given-names></name><name><surname>Kinet</surname><given-names>J-P</given-names></name><name><surname>Witte</surname><given-names>ON</given-names></name></person-group><year>1996</year><article-title>Regulation of btk function by a major autophosphorylation site within the SH3 domain</article-title><source>Immunity</source><volume>4</volume><fpage>515</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(00)80417-3</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pronk</surname><given-names>S</given-names></name><name><surname>Páll</surname><given-names>S</given-names></name><name><surname>Schulz</surname><given-names>R</given-names></name><name><surname>Larsson</surname><given-names>P</given-names></name><name><surname>Bjelkmar</surname><given-names>P</given-names></name><name><surname>Apostolov</surname><given-names>R</given-names></name><name><surname>Shirts</surname><given-names>MR</given-names></name><name><surname>Smith</surname><given-names>JC</given-names></name><name><surname>Kasson</surname><given-names>PM</given-names></name><name><surname>van der Spoel</surname><given-names>D</given-names></name><name><surname>Hess</surname><given-names>B</given-names></name><name><surname>Lindahl</surname><given-names>E</given-names></name></person-group><year>2013</year><article-title>GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit</article-title><source>Bioinformatics</source><volume>29</volume><fpage>845</fpage><lpage>854</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btt055</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rawlings</surname><given-names>DJ</given-names></name><name><surname>Scharenberg</surname><given-names>AM</given-names></name><name><surname>Park</surname><given-names>H</given-names></name><name><surname>Wahl</surname><given-names>MI</given-names></name><name><surname>Lin</surname><given-names>S</given-names></name><name><surname>Kato</surname><given-names>RM</given-names></name><name><surname>Fluckiger</surname><given-names>AC</given-names></name><name><surname>Witte</surname><given-names>ON</given-names></name><name><surname>Kinet</surname><given-names>JP</given-names></name></person-group><year>1996</year><article-title>Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases</article-title><source>Science</source><volume>271</volume><fpage>822</fpage><lpage>825</lpage><pub-id pub-id-type="doi">10.1126/science.271.5250.822</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Read</surname><given-names>RJ</given-names></name></person-group><year>1986</year><article-title>Improved Fourier coefficients for maps using phases from partial structures with errors</article-title><source>Acta Crystallographica Section A, Foundations of Crystallography</source><volume>42</volume><fpage>140</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1107/S0108767386099622</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robert</surname><given-names>X</given-names></name><name><surname>Gouet</surname><given-names>P</given-names></name></person-group><year>2014</year><article-title>Deciphering key features in protein structures with the new ENDscript server</article-title><source>Nucleic Acids Research</source><volume>42</volume><fpage>W320</fpage><lpage>W324</lpage><pub-id pub-id-type="doi">10.1093/nar/gku316</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiering</surname><given-names>N</given-names></name><name><surname>Casale</surname><given-names>E</given-names></name><name><surname>Caccia</surname><given-names>P</given-names></name><name><surname>Giordano</surname><given-names>P</given-names></name><name><surname>Battistini</surname><given-names>C</given-names></name></person-group><year>2000</year><article-title>Dimer formation through domain swapping in the crystal structure of the Grb2-SH2−Ac-pYVNV complex</article-title><source>Biochemistry</source><volume>39</volume><fpage>13376</fpage><lpage>13382</lpage><pub-id pub-id-type="doi">10.1021/bi0012336</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seeliger</surname><given-names>MA</given-names></name><name><surname>Young</surname><given-names>M</given-names></name><name><surname>Henderson</surname><given-names>MN</given-names></name><name><surname>Pellicena</surname><given-names>P</given-names></name><name><surname>King</surname><given-names>DS</given-names></name><name><surname>Falick</surname><given-names>AM</given-names></name><name><surname>Kuriyan</surname><given-names>J</given-names></name></person-group><year>2005</year><article-title>High yield bacterial expression of active c-Abl and c-Src tyrosine kinases</article-title><source>Protein Science</source><volume>14</volume><fpage>3135</fpage><lpage>3139</lpage><pub-id pub-id-type="doi">10.1110/ps.051750905</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shears</surname><given-names>SB</given-names></name></person-group><year>2001</year><article-title>Assessing the omnipotence of inositol hexakisphosphate</article-title><source>Cellular Signalling</source><volume>13</volume><fpage>151</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1016/S0898-6568(01)00129-2</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sicheri</surname><given-names>F</given-names></name><name><surname>Moarefi</surname><given-names>I</given-names></name><name><surname>Kuriyan</surname><given-names>J</given-names></name></person-group><year>1997</year><article-title>Crystal structure of the Src family tyrosine kinase Hck</article-title><source>Nature</source><volume>385</volume><fpage>602</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1038/385602a0</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sondhi</surname><given-names>D</given-names></name><name><surname>Cole</surname><given-names>PA</given-names></name></person-group><year>1999</year><article-title>Domain interactions in protein tyrosine kinase csk</article-title><source>Biochemistry</source><volume>38</volume><fpage>11147</fpage><lpage>11155</lpage><pub-id pub-id-type="doi">10.1021/bi990827+</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szwergold</surname><given-names>BS</given-names></name><name><surname>Graham</surname><given-names>RA</given-names></name><name><surname>Brown</surname><given-names>TR</given-names></name></person-group><year>1987</year><article-title>Observation of inositol pentakis-and hexakis-phosphates in mammalian tissues by 31P NMR</article-title><source>Biochemical and Biophysical Research Communications</source><volume>149</volume><fpage>874</fpage><lpage>881</lpage><pub-id pub-id-type="doi">10.1016/0006-291X(87)90489-X</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>X</given-names></name><name><surname>Calderon-Villalobos</surname><given-names>LI</given-names></name><name><surname>Sharon</surname><given-names>M</given-names></name><name><surname>Zheng</surname><given-names>C</given-names></name><name><surname>Robinson</surname><given-names>CV</given-names></name><name><surname>Estelle</surname><given-names>M</given-names></name><name><surname>Zheng</surname><given-names>N</given-names></name></person-group><year>2007</year><article-title>Mechanism of auxin perception by the TIR1 ubiquitin ligase</article-title><source>Nature</source><volume>446</volume><fpage>640</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1038/nature05731</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>SS</given-names></name><name><surname>Kornev</surname><given-names>AP</given-names></name></person-group><year>2011</year><article-title>Protein kinases: evolution of dynamic regulatory proteins</article-title><source>Trends in Biochemical Sciences</source><volume>36</volume><fpage>65</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2010.09.006</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsukada</surname><given-names>S</given-names></name><name><surname>Saffran</surname><given-names>DC</given-names></name><name><surname>Rawlings</surname><given-names>DJ</given-names></name><name><surname>Parolini</surname><given-names>O</given-names></name><name><surname>Allen</surname><given-names>RC</given-names></name><name><surname>Klisak</surname><given-names>I</given-names></name><name><surname>Sparkes</surname><given-names>RS</given-names></name><name><surname>Kubagawa</surname><given-names>H</given-names></name><name><surname>Mohandas</surname><given-names>T</given-names></name><name><surname>Quan</surname><given-names>S</given-names></name><name><surname>Belmont</surname><given-names>JW</given-names></name><name><surname>Cooper</surname><given-names>MD</given-names></name><name><surname>Conley</surname><given-names>ME</given-names></name><name><surname>Witte</surname><given-names>ON</given-names></name></person-group><year>1993</year><article-title>Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia</article-title><source>Cell</source><volume>72</volume><fpage>279</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(93)90667-F</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsukada</surname><given-names>S</given-names></name><name><surname>Simon</surname><given-names>MI</given-names></name><name><surname>Witte</surname><given-names>ON</given-names></name><name><surname>Katz</surname><given-names>A</given-names></name></person-group><year>1994</year><article-title>Binding of beta gamma subunits of heterotrimeric G proteins to the PH domain of Bruton tyrosine kinase</article-title><source>Proceedings of the National Academy of Sciences of USA</source><volume>91</volume><fpage>11256</fpage><lpage>11260</lpage><pub-id pub-id-type="doi">10.1073/pnas.91.23.11256</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tzeng</surname><given-names>SR</given-names></name><name><surname>Lou</surname><given-names>YC</given-names></name><name><surname>Pai</surname><given-names>MT</given-names></name><name><surname>Jain</surname><given-names>ML</given-names></name><name><surname>Cheng</surname><given-names>JW</given-names></name></person-group><year>2000</year><article-title>Solution structure of the human BTK SH3 domain complexed with a proline-rich peptide from p120cbl</article-title><source>Journal of Biomolecular NMR</source><volume>16</volume><fpage>303</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1023/A:1008376624863</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vallejo</surname><given-names>M</given-names></name><name><surname>Jackson</surname><given-names>T</given-names></name><name><surname>Lightman</surname><given-names>S</given-names></name><name><surname>Hanley</surname><given-names>MR</given-names></name></person-group><year>1987</year><article-title>Occurrence and extracellular actions of inositol pentakis- and hexakisphosphate in mammalian brain</article-title><source>Nature</source><volume>330</volume><fpage>656</fpage><lpage>658</lpage><pub-id pub-id-type="doi">10.1038/330656a0</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Kadlecek</surname><given-names>TA</given-names></name><name><surname>Au-Yeung</surname><given-names>BB</given-names></name><name><surname>Goodfellow</surname><given-names>HE</given-names></name><name><surname>Hsu</surname><given-names>LY</given-names></name><name><surname>Freedman</surname><given-names>TS</given-names></name><name><surname>Weiss</surname><given-names>A</given-names></name></person-group><year>2010</year><article-title>ZAP-70: an essential kinase in T-cell signaling</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>2</volume><fpage>a002279</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a002279</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>PJ</given-names></name><name><surname>Fairall</surname><given-names>L</given-names></name><name><surname>Santos</surname><given-names>GM</given-names></name><name><surname>Schwabe</surname><given-names>JW</given-names></name></person-group><year>2012</year><article-title>Structure of HDAC3 bound to co-repressor and inositol tetraphosphate</article-title><source>Nature</source><volume>481</volume><fpage>335</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1038/nature10728</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>A</given-names></name><name><surname>Littman</surname><given-names>DR</given-names></name></person-group><year>1994</year><article-title>Signal transduction by lymphocyte antigen receptors</article-title><source>Cell</source><volume>76</volume><fpage>263</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(94)90334-4</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winn</surname><given-names>MD</given-names></name><name><surname>Ballard</surname><given-names>CC</given-names></name><name><surname>Cowtan</surname><given-names>KD</given-names></name><name><surname>Dodson</surname><given-names>EJ</given-names></name><name><surname>Emsley</surname><given-names>P</given-names></name><name><surname>Evans</surname><given-names>PR</given-names></name><name><surname>Keegan</surname><given-names>RM</given-names></name><name><surname>Krissinel</surname><given-names>EB</given-names></name><name><surname>Leslie</surname><given-names>AG</given-names></name><name><surname>McCoy</surname><given-names>A</given-names></name><name><surname>McNicholas</surname><given-names>SJ</given-names></name><name><surname>Murshudov</surname><given-names>GN</given-names></name><name><surname>Pannu</surname><given-names>NS</given-names></name><name><surname>Potterton</surname><given-names>EA</given-names></name><name><surname>Powell</surname><given-names>HR</given-names></name><name><surname>Read</surname><given-names>RJ</given-names></name><name><surname>Vagin</surname><given-names>A</given-names></name><name><surname>Wilson</surname><given-names>KS</given-names></name></person-group><year>2011</year><article-title>Overview of the CCP4 suite and current developments</article-title><source>Acta Crystallographica Section D, Biological Crystallography</source><volume>67</volume><fpage>235</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1107/S0907444910045749</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>WI</given-names></name><name><surname>Voegtli</surname><given-names>WC</given-names></name><name><surname>Sturgis</surname><given-names>HL</given-names></name><name><surname>Dizon</surname><given-names>FP</given-names></name><name><surname>Vigers</surname><given-names>GPA</given-names></name><name><surname>Brandhuber</surname><given-names>BJ</given-names></name></person-group><year>2010</year><article-title>Crystal structure of human AKT1 with an allosteric inhibitor reveals a new Mode of kinase inhibition</article-title><source>PLOS ONE</source><volume>5</volume><fpage>e12913</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0012913</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Harrison</surname><given-names>SC</given-names></name><name><surname>Eck</surname><given-names>MJ</given-names></name></person-group><year>1997</year><article-title>Three-dimensional structure of the tyrosine kinase c-Src</article-title><source>Nature</source><volume>385</volume><fpage>595</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1038/385595a0</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>H</given-names></name><name><surname>Hendrickson</surname><given-names>WA</given-names></name></person-group><year>1996</year><article-title>Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation</article-title><source>Nature</source><volume>384</volume><fpage>484</fpage><lpage>489</lpage><pub-id pub-id-type="doi">10.1038/384484a0</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>York</surname><given-names>JD</given-names></name><name><surname>Odom</surname><given-names>AR</given-names></name><name><surname>Murphy</surname><given-names>R</given-names></name><name><surname>Ives</surname><given-names>EB</given-names></name><name><surname>Wente</surname><given-names>SR</given-names></name></person-group><year>1999</year><article-title>A phospholipase C-dependent inositol polyphosphate kinase pathway required for efficient messenger RNA export</article-title><source>Science</source><volume>285</volume><fpage>96</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1126/science.285.5424.96</pub-id></element-citation></ref></ref-list></back><sub-article article-type="article-commentary" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.06074.025</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Cole</surname><given-names>Philip A</given-names></name><role>Reviewing editor</role><aff><institution>Johns Hopkins University School of Medicine</institution>, <country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see <ext-link ext-link-type="uri" xlink:href="http://elifesciences.org/review-process">review process</ext-link>). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.</p></boxed-text><p>Thank you for sending your work entitled “Autoinhibition of Bruton's tyrosine kinase (Btk) and activation by soluble inositol hexakisphosphate” for consideration at <italic>eLife</italic>. Your article has been favorably evaluated by Tony Hunter (Senior editor) and 3 reviewers, one of whom is a member of our Board of Reviewing Editors.</p><p>The Reviewing editor and two other reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.</p><p>The manuscript by Qi Wang et al concerns a comprehensive biochemical analysis of the regulation of Btk (Bruton's tyrosine kinase) and its unexpected activation by IP<sub>6</sub>. Btk is of broad interest in immune signaling and as a drug target. This paper enlightens the community about several very interesting and important features regarding Btk regulation: 1) The kinase domain is held in an inhibited state by the SH2 and SH3 domains in a manner analogous to Src (and Abl);</p><p>2) Unique to Btk, its PH domain participates directly through the kinase N-lobe with the SH2 and SH3 domain to suppress the kinase domain;</p><p>3) Vesicle bound PIP<sub>3</sub> can activate Btk by inducing dimerization;</p><p>4) Soluble IP<sub>6</sub> can activate Btk by binding a non-canonical surface of the PH domain and promoting dimerization.</p><p>The comprehensive model of Btk regulation described in this manuscript derives from several high-resolution crystal structures, enzymologic analysis of autophosphorylation as well as peptide phosphorylation in the presence of various activators, site-directed mutagenesis, and molecular dynamics simulations. The discovery of IP<sub>6</sub> regulation is perhaps the most special aspect of the manuscript and should generate substantial interest in the tyrosine kinase and pleckstrin homology domain fields. While the authors rightly cite Huang et al, <underline>Science (2007)</underline>,which reports that soluble IP<sub>4</sub> can activate ITK tyrosine kinase, our read of this study is that it minimally characterizes this putative activation, which in vitro was quite marginal. In summary, the current manuscript is an excellent fit for <italic>eLife</italic>. We ask the authors to consider the comments below.</p><p>There is no mention in the Introduction of the prior Btk structures reported. A search of the PDB reveals that there are over 30 structures of various Btk domains in active and inactive states. It would be helpful to the reader to briefly summarize the known Btk domain structures and include a statement indicating that although the structures of the individual Btk domains are established, the relationships between the kinase domain and the SH2, SH3 and PH-TH domains were not known prior to the current manuscript.</p><p>Major comments:</p><p>The role of IP<sub>6</sub> as a glue holding neighboring PH domains together is somewhat reminiscent of a related role for soluble IP<sub>4</sub>/6 in stabilizing HDAC/corepressor complexes (CJ Millard et al, Mol Cell 51, 57-67,2013). The authors may wish to compare the Btk and corepressor inositol phosphate-containing structures and comment on the relationship if appropriate.</p><p>We were unable to find the specific peptide sequence of the kinase substrate or its concentration in the Methods. While not absolutely essential, it would also be informative to know what the Km of the peptide is and whether this changes in different states of Btk activation. If there were Km differences among particular Btk conformational states, for example IP<sub>6</sub> rather than PIP<sub>3</sub> activation, this could give rise to different cellular signaling outputs.</p><p>In their full-length Btk model, the SH3 domain and the PH domain appear to make electrostaic interactions with each other (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Do the authors predict that this surface is modulated by IP<sub>6</sub> or PIP<sub>3</sub> binding? Likewise, is there any reason to think that ligation of the SH3 domain by external ligands impacts this SH3/PH interaction?</p><p>Although the authors show that PIP<sub>3</sub>-derived IP<sub>4</sub> binds more tightly to the Btk PH domain than IP<sub>6</sub> (Kd of 30 nM vs. 250 nM), it is interesting to consider that high concentrations (&gt;20 µM) of soluble IP<sub>6</sub> could conceivably compete Btk off of the PIP<sub>3</sub> containing membrane. Thus, one way to consider the importance of the Btk allosteric binding site for IP<sub>6</sub> is that it is needed to prevent down-regulation by competition of IP<sub>6</sub> for PIP<sub>3</sub> at the PIP<sub>3</sub> binding site. If true, Btk membrane binding may be an overstated facet of its regulation, as the authors also suggest. It will be fascinating in future studies to investigate selective mutants in vivo to dissect the relative contributions of PIP<sub>3</sub> and IP<sub>6</sub> in signaling.</p><p>Alternatively, just as IP<sub>6</sub> might stimulate dimerization of membrane-tethered Btk, as suggested in the Conclusions, might it not also enhance the affinity (avidity) of Btk for PIP<sub>3</sub>-containing membranes by promoting dimerization? This would have the effect of 'sensitizing' Btk to PIP<sub>3</sub> levels, and could be important. Such an effect of IP<sub>6</sub> (or IP<sub>7</sub> or IP<sub>8</sub>) could also/alternatively counteract inhibition of PH domain function by competition at the canonical site (as suggested by Chakraborty et al for Akt: Cell 143, 897). It might thus selectively 'spare' Btk from such inhibition?</p><p>In the beginning of the Results and Discussion section, the authors describe the difference in the angles for the kinase SH3 domain with respect to other kinases and they explain the differences in orientation of the SH2 and SH3 domains, saying: “Coupling between the SH3 and SH2 domains may therefore be somewhat different in these kinases.” Although this may be true, it is also possible that there is not a fixed orientation in solution between the different domains and the differences reflect different arrangements captured by the crystals. The authors also say that: ”diffuse electron density for the SH2 shows that this part of the polypeptide chain occupies a range of positions and adopts multiple conformations“. This statement seems to support such an idea.</p><p>Also in the Results and Discussion section, the authors say that: “… nearly identical to those determined previously using NMR”. They should include RMSD for the C-alphas that were aligned.</p><p>This sentence, in the same section of the text: “The domain swap occurs in the same location within the SH2 domain as a similar swap seen in a Grb2 SH2-domain crystal structure.” From the drawing this similarity is not so apparent. They use the same helix against the same beta sheet, but the orientation of the two monomers appears different. In Grb2 the helices are essentially parallel to the beta-sheet whereas in Btk, these helices seem to be perpendicular.</p><p>The authors say that it is unlikely “that a domain-swapped dimer” is physically important. That being the case, the authors may wish to consider reducing the overall discussion about domain swapping.</p><p>In the Results and Discussion, it says that “r.m.s. deviation from c-Src is 2.3 Å for the 24 α-carbons”. This seems to be a rather large deviation for so few carbons.</p><p>In that same section of the article, the authors call an Arg-Phe interaction an “amino-aromatic interaction”. Is this actually amino (cation)-aromatic pair, or is it a π-type (Pi-type) interaction between the guadinium of the Arg and the aromatic ring of the Phe?</p><p>In the subsection “Structure of a PH-TH-kinase construct of Btk”, it says: “The PH-TH module contacts the kinase N-lobe. The interface differs from the one found in Akt1”. Is this because they are intrinsically different or because of the deletion of the SH2 and SH3 domains? Some comment on this could be helpful.</p><p>Subsection headed “A structural model for full-length Btk”: it is not very clear what the cause is, but the deviations between the crystallographic structures and the ones at the end of the trajectories appear to be large. It is not very clear what these trajectories were probing and what the implications are for their having departed so significantly from the original structures?</p><p>The manuscript says, in the “Activation of Btk by IP<sub>6</sub> in solution” section: “but these required higher protein concentration and longer times for appreciable autophosphylation than did IP<sub>6</sub>IP6.” Looking at <xref ref-type="fig" rid="fig5">Figure 5B</xref> the Coomassie-blue for some of the IP<sub>5</sub> doesn't show higher protein concentration.</p><p>Subsection headed “The canonical lipid-binding pocket of the PH-TH module is not critical for IP<sub>6</sub>-mediated Btk activation”: when the authors note that R28C/N24E abolishes IP<sub>4</sub> binding and weakens IP<sub>6</sub> binding by 20-40-fold using ITC, they appear to conclude that the residual binding is solely due to the separate IP<sub>6</sub> site. Is it possible that the double mutant still allows for IP<sub>6</sub> binding to the IP<sub>4</sub> site? Perhaps the authors can clarify this section a bit more.</p><p>Subsection headed “Structure of the IP<sub>6</sub>-bound PH-TH module”: it is not said, although one can assume, that the dimers are two-fold symmetric. If that is the case it is not very clear whether or not the open-ended chain is a consequence of the crystal lattice rather than being biologically relevant. Therefore, the binding site that is formed by two molecules in the context of the open-ended chain of dimers may not be present in solution. The authors appear to imply that the IP<sub>6</sub> interaction site is mostly determined by one of the chains. If that were the case and IP<sub>6</sub> binds to that site even in the absence of the dimer-formed open-ended chain, then shouldn't one have observed a more complex stoichiometry in the ITC experiments (which shows an n∼1)? More explanation here could be helpful.</p><p>The section on IP<sub>6</sub> regulation is fairly lengthy given the degree of speculation. The authors could consider condensing this.</p><p>In the beginning of the Results and Discussion, it could be helpful to include a short introduction indicating which structures were determined as part of this work, to what resolution, and a reference to <xref ref-type="table" rid="tbl2">Table 2</xref>.</p><p>It would be interesting to know whether the orientation of the IP<sub>6</sub> in the peripheral site is well defined or not. IP<sub>6</sub> binding to such a 'flat' (as the authors put it) site is often heterogeneous in pose, but the data in <xref ref-type="fig" rid="fig5">Figure 5D</xref> suggest that this might not be the case here, as does the second paragraph in “The peripheral binding site is critical for IP<sub>6</sub>-mediated Btk activation”. Some comment on stereospecificity would be helpful for those who think about IP<sub>6</sub> binding sites. Perhaps a density panel could be added to <xref ref-type="fig" rid="fig7">Figure 7</xref> or its supplement?</p><p>In reflecting on the organization of the paper, one suggestion would be to place <xref ref-type="fig" rid="fig2">Figure 2</xref> (“Structure of a PH-TH-kinase construct of Btk”) before <xref ref-type="fig" rid="fig1">Figure 1</xref> (“Crystal structure of the Btk SH3-SH2-kinase module”). The story might flow/unfold better if the discovery of the potential autoinhibitory role of the PH-TH region leads into discovery of the Src-like disposition of domains in the Src-like module, then wrapped up nicely by the work in <xref ref-type="fig" rid="fig3">Figure 3</xref> on whole Btk.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.06074.026</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><p><italic>There is no mention in the Introduction of the prior Btk structures reported. A search of the PDB reveals that there are over 30 structures of various Btk domains in active and inactive states. It would be helpful to the reader to briefly summarize the known Btk domain structures and include a statement indicating that although the structures of the individual Btk domains are established, the relationships between the kinase domain and the SH2, SH3 and PH-TH domains were not known prior to the current manuscript</italic>.</p><p>We appreciated this point. We have added two sentences in the Introduction summarizing the previously determined structures of Btk fragments and have prepared a supplemental table (<xref ref-type="table" rid="tbl1">Table 1</xref>) that lists all the structures of Btk and other Tec family kinases in the Protein Data Bank, along with the accession codes.</p><p><italic>Major comments:</italic></p><p><italic>The role of IP</italic><sub><italic>6</italic></sub> <italic>as a glue holding neighboring PH domains together is somewhat reminiscent of a related role for soluble IP</italic><sub><italic>4/6</italic></sub> <italic>in stabilizing HDAC/corepressor complexes (CJ Millard et al, Mol Cell 51, 57-67, 2013). The authors may wish to compare the Btk and corepressor inositol phosphate-containing structures and comment on the relationship if appropriate</italic>.</p><p>We have added a paragraph in the Results section discussing the role of IP<sub>4</sub> in regulating the HDAC/corepressor complex, and compared that with the role of IP<sub>6</sub> in regulating Btk activation. The mechanism of IP6-induced transient Btk dimerization is fundamentally different from that of the regulation of HDACs by IP<sub>4</sub>. We point out in the revised manuscript that in case of Btk, the peripheral IP<sub>6</sub> binding site is located next to the Saraste dimer interface, and IP6 is not directly involved in any interactions between the two Btk subunits in the Saraste dimer.</p><p><italic>We were unable to find the specific peptide sequence of the kinase substrate or its concentration in the Methods. While not absolutely essential, it would also be informative to know what the Km of the peptide is and whether this changes in different states of Btk activation. If there were Km differences among particular Btk conformational states, for example IP</italic><sub><italic>6</italic></sub> <italic>rather than PIP</italic><sub><italic>3</italic></sub> <italic>activation, this could give rise to different cellular signaling outputs</italic>.</p><p>We apologize for not including this information in the original manuscript. We have added the peptide sequence and the Km value for the peptide for phosphorylated full-length Btk in the Materials and methods section. We did not measure the Km values for various Btk states, and we agree that this could be an interesting subject for the future studies.</p><p><italic>In their full-length Btk model, the SH3 domain and the PH domain appear to make electrostaic interactions with each other (</italic><xref ref-type="fig" rid="fig4"><italic>Figure 4B</italic></xref><italic>). Do the authors predict that this surface is modulated by IP</italic><sub><italic>6</italic></sub> <italic>or PIP</italic><sub><italic>3</italic></sub> <italic>binding? Likewise, is there any reason to think that ligation of the SH3 domain by external ligands impacts this SH3/PH interaction?</italic></p><p>This point made us realize that we had not provided structural diagrams that clearly showed the location of the peripheral IP<sub>6</sub> site with respect to other regulatory elements. We don’t think that IP<sub>6</sub> or PIP<sub>3</sub> binding will directly disassemble the inactive conformation of Btk, because both binding sites are located distal to the interface between the PH-TH module and the Src-like module. We have clarified this by marking both binding sites in our cartoon illustrations in all figures and have added corresponding sentences in the Results section. On the other hand, the ligation of the SH3 domain by external ligands will likely disassemble inactive conformation of Btk. We now note this in the Results section.</p><p><italic>Although the authors show that PIP</italic><sub><italic>3</italic></sub><italic>-derived IP</italic><sub><italic>4</italic></sub> <italic>binds more tightly to the Btk PH domain than IP</italic><sub><italic>6</italic></sub> <italic>(Kd of 30 nM vs. 250 nM), it is interesting to consider that high concentrations (&gt;20 µM) of soluble IP</italic><sub><italic>6</italic></sub> <italic>could conceivably compete Btk off of the PIP</italic><sub><italic>3</italic></sub> <italic>containing membrane. Thus, one way to consider the importance of the Btk allosteric binding site for IP</italic><sub><italic>6</italic></sub> <italic>is that it is needed to prevent down-regulation by competition of IP</italic><sub><italic>6</italic></sub> <italic>for PIP</italic><sub><italic>3</italic></sub> <italic>at the PIP</italic><sub><italic>3</italic></sub> <italic>binding site. If true, Btk membrane binding may be an overstated facet of its regulation, as the authors also suggest. It will be fascinating in future studies to investigate selective mutants</italic> in vivo <italic>to dissect the relative contributions of PIP</italic><sub><italic>3</italic></sub> <italic>and IP</italic><sub><italic>6</italic></sub> <italic>in signaling</italic>.</p><p>This is an excellent point. We agree with reviewers’ comments and have expanded our discussion on the potential roles of IP<sub>6</sub> in regulating membrane-tethered Btk.</p><p><italic>Alternatively, just as IP</italic><sub><italic>6</italic></sub> <italic>might stimulate dimerization of membrane-tethered Btk, as suggested in the Conclusions, might it not also enhance the affinity (avidity) of Btk for PIP</italic><sub><italic>3</italic></sub><italic>-containing membranes by promoting dimerization? This would have the effect of 'sensitizing' Btk to PIP</italic><sub><italic>3</italic></sub> <italic>levels, and could be important. Such an effect of IP</italic><sub><italic>6</italic></sub> <italic>(or IP</italic><sub><italic>7</italic></sub> <italic>or IP</italic><sub><italic>8</italic></sub><italic>) could also/alternatively counteract inhibition of PH domain function by competition at the canonical site (as suggested by Chakraborty et al for Akt: Cell 143, 897). It might thus selectively 'spare' Btk from such inhibition?</italic></p><p>We appreciate this point as well, and have included this in the concluding section.</p><p><italic>In the beginning of the Results and Discussion section, the authors describe the difference in the angles for the kinase SH3 domain with respect to other kinases and they explain the differences in orientation of the SH2 and SH3 domains, saying: “Coupling between the SH3 and SH2 domains may therefore be somewhat different in these kinases.” Although this may be true, it is also possible that there is not a fixed orientation in solution between the different domains and the differences reflect different arrangements captured by the crystals. The authors also say that: “diffuse electron density for the SH2 shows that this part of the polypeptide chain occupies a range of positions and adopts multiple conformations”. This statement seems to support such an idea</italic>.</p><p>We agree with this comment.</p><p><italic>Still in the Results and Discussion section, the authors say that: “… nearly identical to those determined previously using NMR”. They should include RMSD for the C-alphas that were aligned</italic>.</p><p>We thank the reviewers for pointing this out. We have calculated the RMSD value as suggested by the reviewers and added it to the Results section.</p><p><italic>This sentence, in the same section of the text: “The domain swap occurs in the same location within the SH2 domain as a similar swap seen in a Grb2 SH2-domain crystal structure.” From the drawing this similarity is not so apparent. They use the same helix against the same beta sheet, but the orientation of the two monomers appears different. In Grb2 the helices are essentially parallel to the beta-sheet whereas in Btk, these helices seem to be perpendicular</italic>.</p><p>The relative orientation of the two subunits in the Btk SH2 dimer is rotated by about 90° with respect to that of the Grb2 SH2 dimer, as noted by the reviewers. We have deleted the word “similar” and replaced it by “domain”. The sentence now reads: “The domain swap occurs in the same location within the SH2 domain as a domain swap seen in a Grb2 SH2-domain crystal structure.”</p><p><italic>The authors say that it is unlikely “that a domain-swapped dimer” is physically important. That being the case, the authors may wish to consider reducing the overall discussion about domain swapping</italic>.</p><p>We have considered this point. We have, however, decided to retain the discussion because the domain swap was an unexpected feature of the crystal structure.</p><p><italic>In the Results and Discussion, it says that “r.m.s. deviation from c-Src is 2.3 Å for the 24 α-carbons”. This seems to be a rather large deviation for so few carbons</italic>.</p><p>The activation loop is a highly flexible part of the kinase domain. For example, when the active and inactive conformation of these 24 Cα atoms are compared between an active (PDB: 3LCK) and inactive (PDB: 1QCF) Src kinase conformation, the rms deviation is 11 Å. Thus 2.3 Å indicates that the conformations of the activation loops are similar.</p><p><italic>In that same section of the article, the authors call an Arg-Phe interaction an “amino-aromatic interaction”. Is this actually amino (cation)-aromatic pair, or is it a π-type (Pi-type) interaction between the guadinium of the Arg and the aromatic ring of the Phe?</italic></p><p>We have confirmed that “amino-aromatic” is a better description for these interactions in the crystal structure.</p><p><italic>In the subsection “Structure of a PH-TH-kinase construct of Btk”, it says: “The PH-TH module contacts the kinase N-lobe. The interface differs from the one found in Akt1”. Is this because they are intrinsically different or because of the deletion of the SH2 and SH3 domains? Some comment on this could be helpful</italic>.</p><p>We thank the reviewers for pointing out this potential confusing statement in our manuscript. The PHkinase interface in Btk is very different from that in Akt1, and we have clarified this by adding a couple of sentences in the corresponding sections in the Results.</p><p><italic>Subsection headed “A structural model for full-length Btk”: it is not very clear what the cause is, but the deviations between the crystallographic structures and the ones at the end of the trajectories appear to be large</italic>. <italic>It is not very clear what these trajectories were probing and what the implications are for their having departed so significantly from the original structures?</italic></p><p>We thank the reviewers for pointing this out and we apologize that we did not make this clear in the manuscript. The relatively large deviation arises from the pivoting motions of the molecule during molecule dynamic simulations, and the use of only the C lobe of the kinase to align these structures, which amplified the deviations. The overall conformation of Btk at the end of the trajectories is actually very similar to the initial structure. We have now explained this in the Result section, and state that the rms deviation between the initial and final structures is only 2.3 Å when the alignment is done on the entire Src-like module.</p><p><italic>The manuscript says, in the “Activation of Btk by IP</italic><sub><italic>6</italic></sub> <italic>in solution” section: “but these required higher protein concentration and longer times for appreciable autophosphylation than did IP</italic><sub><italic>6</italic></sub><italic>.” Looking at</italic> <xref ref-type="fig" rid="fig5"><italic>Figure 5B</italic></xref> <italic>the Coomassie-blue for some of the IP</italic><sub><italic>5</italic></sub> <italic>doesn't show higher protein concentration</italic>.</p><p>Perhaps the confusion here arises because the results of two different experiments (two different gels) are shown in Panel 5B. The top gel in this panel has lower protein concentration (2 μM Btk), shorter reaction time (5 minutes) and shorter exposure time. The bottom gel has higher Btk concentration (4 μM Btk), longer reaction time (10 minutes) and the gel has been exposed for a longer time. The figure legend has been modified to make this clearer.</p><p><italic>Subsection headed “The canonical lipid-binding pocket of the PH-TH module is not critical for IP</italic><sub><italic>6</italic></sub><italic>-mediated Btk activation”: when the authors note that R28C/N24E abolishes IP</italic><sub><italic>4</italic></sub> <italic>binding and weakens IP</italic><sub><italic>6</italic></sub> <italic>binding by 20-40-fold using ITC, they appear to conclude that the residual binding is solely due to the separate IP</italic><sub><italic>6</italic></sub> <italic>site. Is it possible that the double mutant still allows for IP</italic><sub><italic>6</italic></sub> <italic>binding to the IP</italic><sub><italic>4</italic></sub> <italic>site? Perhaps the authors can clarify this section a bit more</italic>.</p><p>In ITC experiments, we saw no detectable binding when we added IP6 to a PH-TH module with mutations at both the canonical and the peripheral sites, which confirms that the residual binding of IP<sub>6</sub> to the IP<sub>4</sub>-binding deficient mutant is due to binding at the peripheral binding site. This is stated in the subsection “The peripheral binding site is critical for IP<sub>6</sub>-mediated Btk activation”.</p><p><italic>Subsection headed “Structure of the IP</italic><sub><italic>6</italic></sub><italic>-bound PH-TH module”: it is not said, although one can assume, that the dimers are two-fold symmetric. If that is the case it is not very clear whether or not the open-ended chain is a consequence of the crystal lattice rather than being biologically relevant. Therefore, the binding site that is formed by two molecules in the context of the open-ended chain of dimers may not be present in solution. The authors appear to imply that the IP</italic><sub><italic>6</italic></sub> <italic>interaction site is mostly determined by one of the chains. If that were the case and IP</italic><sub><italic>6</italic></sub> <italic>binds to that site even in the absence of the dimer-formed open-ended chain, then shouldn't one have observed a more complex stoichiometry in the ITC experiments (which shows an n∼1)? More explanation here could be helpful</italic>.</p><p>We thank the reviewers for pointing out this potentially confusing point, which was not well addressed in the original manuscript. We agree that this chain of dimers is unlikely to be biologically relevant, and the dimer that matters for the Btk activation is the Saraste dimer, which we discuss extensively in the paper. We have now clarified this by reducing the discussion of the open-ended chain of dimers in the Results section, and adding several sentences to make it clear that the open-ended chain is likely to be only a feature of the crystals.</p><p><italic>The section on IP</italic><sub><italic>6</italic></sub> <italic>regulation is fairly lengthy given the degree of speculation. The authors could consider condensing this</italic>.</p><p>The molecular mechanism by which IP6 causes transient dimerization of Btk remains puzzling because we do not detect dimers even at concentrations as high as 30 μM. This section makes two points that we believe are important: (1) the conformation of the unliganded, monomeric Btk is likely to be different from that seen in the Saraste dimer and (2) changes in surface electrostatics can activate Btk in the absence of IP6. For these reasons we would prefer to retain this section.</p><p><italic>In the beginning of the Results and Discussion, it could be helpful to include a short introduction indicating which structures were determined as part of this work, to what resolution, and a reference to</italic> <xref ref-type="table" rid="tbl2"><italic>Table 2</italic></xref>.</p><p>We thank the reviewers for this suggestion. We have added a section in the beginning of the Results and Discussion summarizing our crystallographic work (see ”Structural analysis of Btk”).</p><p><italic>It would be interesting to know whether the orientation of the IP</italic><sub><italic>6</italic></sub> <italic>in the peripheral site is well defined or not. IP</italic><sub><italic>6</italic></sub> <italic>binding to such a 'flat' (as the authors put it) site is often heterogeneous in pose, but the data in</italic> <xref ref-type="fig" rid="fig5"><italic>Figure 5D</italic></xref> <italic>suggest that this might not be the case here, as does the second paragraph in “The peripheral binding site is critical for IP</italic><sub><italic>6</italic></sub><italic>-mediated Btk activation”. Some comment on stereospecificity would be helpful for those who think about IP</italic><sub><italic>6</italic></sub> <italic>binding sites. Perhaps a density panel could be added to</italic> <xref ref-type="fig" rid="fig7"><italic>Figure 7</italic></xref> <italic>or its supplement?</italic></p><p>We thank the reviewers for pointing out this important issue, which was not emphasized enough in the original manuscript. The disposition of the peripheral IP<sub>6</sub> molecule can be determined unambiguously from the electron density because the phosphate group at position 2 juts out from the plane of the myo-inositol ring. This agrees well with our biochemical data that the phosphate at position 2 is likely to be critical for IP<sub>6</sub> activation of Btk. We have added a figure showing electron density for IP<sub>6</sub> at the peripheral site in <xref ref-type="fig" rid="fig7">Figure 7</xref>, and further explained the specificity of IP<sub>6</sub> for this site in the Results section.</p><p><italic>In reflecting on the organization of the paper, one suggestion would be to place</italic> <xref ref-type="fig" rid="fig2"><italic>Figure 2</italic></xref> <italic>(“Structure of a PH-TH-kinase construct of Btk”) before</italic> <xref ref-type="fig" rid="fig1"><italic>Figure 1</italic></xref> <italic>(“Crystal structure of the Btk SH3-SH2-kinase module”). The story might flow/unfold better if the discovery of the potential autoinhibitory role of the PH-TH region leads into discovery of the Src-like disposition of domains in the Src-like module, then wrapped up nicely by the work in</italic> <xref ref-type="fig" rid="fig3"><italic>Figure 3</italic></xref> <italic>on whole Btk</italic>.</p><p>We appreciate this point. We have found it to be challenging to weave all the threads of the discussion into one coherent narrative. At the end we find it easier to stay with the current organization.</p><p>In addition to these changes made to the manuscript, in response to the reviewers’ comments, we have added one new figure (<xref ref-type="fig" rid="fig9s1">Figure 9–figure supplement 1B</xref>). We used a simple Michaelis-Menten scheme, shown in this figure, to model the autophosphorylation kinetics of Btk. We make two assumptions in this scheme: first, that IP<sub>6</sub> binding increases the on-rate of dimer formation of Btk by a factor of 10, and that once Btk is phosphorylated, the catalytic rate constant for transautophosphorylation increases by a factor of 10. Using physically reasonable values for the on and off rates and the catalytic rates we show that a small increase in on-rate for Btk dimer formation leads to a dramatic increase in the rate of autophosphorylation, even though the concentration of Btk is two orders of magnitude below the value of the dissociation constant. We think that this simple calculation helps explain an observation that might otherwise be counter-intuitive to some readers, which is that IP<sub>6</sub> can activate Btk at Btk concentrations that are well below the dissociation constant for dimerization. Text referring to this new figure is in the last paragraph of “Fusing the Btk PH-TH module to the catalytic module of c-Abl promotes autophosphorylation of c-Abl in the prescence of IP<sub>6</sub>”.</p></body></sub-article></article>